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INTRODUCTION 
In our complex, technological, and rather impersonal society, 
individuals often find themselves involved in activities directed by others, 
about which they know very little. Just as often, individuals may feel that 
they have not been afforded an adequate opportunity to agree to their own 
participation. Informed consent is the voluntary agreement of a person to 
participate in treatment, research, or any other activity, based upon an 
adequate understanding of salient aspects of that activity. The concept of 
informed consent has gradually developed through the evolution of both 
case law and biomedical ethics. 
It is generally agreed that informed consent procures are required 
whenever intrusion, risk, or questionable purposes are evident in a 
participatory activity (Beauchamp & Childress, 1979). The provision of 
informed consent to both research and treatment has become accepted 
practice in medicine and psychology. Further, it follows that as medical or 
research procedures become more intrusive or risky, the argument to 
provide informed consent becomes more compelling. A good example of 
an intrusive medical and psychological procedure is intensive treatment for 
chemical dependency. In chemical dependency treatment, patients are 
confronted by both professional staff and fellow patients about their 
behavior, attitudes, and honesty. Physical freedom is often curtailed 
(inpatient and residential treatment), privacy is invaded (no closed doors in 
patient rooms allowed, mandatory urinalysis), and the significant 
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discomfort of detoxification is experienced by a sizable portion of the 
treatment population. 
In informed consent, "consent" refers to the voluntariness of the 
person's agreement to participate. "Informed" refers to the provision of 
pertinent information about the activity and the understanding of that 
information by the person who is considering involvement. Beauchamp 
and Childress (1979) state that "the information element of informed 
consent refers to adequate disclosure of information and adequate 
comprehension by patients or subjects of what is disclosed" (p. 66). 
Inherent in the provision of fully informed consent is the assumption that 
the subject or patient has adequately understood the information offered to 
him or her. The usual and customary procedure for provision of informed 
consent is the presentation of a printed consent form along with the 
request that the subject or patient read it and sign a statement indicating 
agreement to participate (Grundner, 1980; Morrow, 1980). Paradoxically, 
while informed consent procedures are clearly indicated for individuals 
who are in treatment for alcohol dependency, research suggests that their 
chronic excessive use of alcohol often results in cognitive impairment 
which may limit their ability to comprehend consent information, as 
commonly presented in written form. 
Several researchers have investigated methods which offer potential 
enhancement of consent information by patients and subjects. In an 
analysis of the dynamics of reading, Adams (1982) noted that highly 
coherent text material contains greater redundancy of information than 
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less coherent material. Some researchers (e.g., Miller & Willner, 1974; 
Taub & Baker, 1983) have incorporated increased redundancy into 
designs of consent information, intended to enhance comprehension and 
recall. 
Another promising and innovative technique is the use of videotaped 
presentations of consent information (Barbour & Blumenkrantz, 1978; 
Tymchuk, Ouslander, & Rader, 1986). Through the use of video format, 
the potential limiting effects of poor reading ability and short attention span 
may be overcome. 
The goal of this study was to investigate the effects of these two 
promising techniques on comprehension when used in the presentation of 
consent information to chronic alcoholics. The study investigated the 
effect of information redundancy and media format upon the 
comprehension of consent information by persons in treatment for chronic 
alcohol dependency. Consent information was presented to subjects via 
two formats, printed information sheets and a videotaped presentation. 
Each of the two formats was presented either with a single delivery of 
each element of consent information or with each element of consent 
information presented twice. The goal of the study was to clarify the 
potential contribution of these factors toward the provision of fully informed 
consent by alcoholics in both the research and treatment settings. In 
addition to an analysis of the effects of the two variables of main interest, 
the relationship of several other independent variables to comprehension 
of the consent information was examined. 
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REVIEW OF THE LITERATURE 
A Brief History of Informed Consent 
Tlie Beginnings of Informed Consent 
The doctrine of informed consent to treatment is of relatively recent 
origin, yet its roots extend as far back as the Code of Hammurabi. Written 
in the 18th century B. C., this code included the first recorded cultural 
effort to protect patients from unskilled or fraudulent doctors (Hammurabi, 
1960). Although sanctions were limited to the practice of surgery, exacting 
penalties for therapeutic failure, this recognition of medicine as a special 
undertaking, carrying with it special obligations, signaled the beginning of 
the long evolution of medical ethics. 
Codified regulation of medical practice was more stringent under the 
Egyptian Pharaohs. Egyptian physicians provided treatment in strict 
accordance with officially approved written protocols. If they deviated from 
accepted practice, and their patient died, they were subject to the death 
penalty (Carrick, 1985). 
Under ancient formulations, the rights of patients were protected, albeit 
in a limited fashion, by harsh regulation of physician behavior. These 
regulations, however, took no note of the patient as a partner in his or her 
medical treatment. Instead, the patient was viewed as a passive recipient 
of purchased services. 
By the Classical Age of Greece, physicians enjoyed the status of 
craftsmen, seen to be in command of a specialized body of knowledge. In 
Homer's time (c. 850 B. C ), the physician held social status similar to the 
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spear maker and the singer (Carrick, 1985). Interestingly, ethical 
constraints on physicians in ancient Greece, as during later Roman times, 
were largely voluntary, with few behaviors proscribed by law. 
The earliest, and certainly the most familiar, complete code of medical 
ethics was the so-called Hippocratic Oath. Scholars no longer attribute its 
authorship to the historical individual Hippocrates but instead suggest an 
origin which is partly of the Hippocratic school, partly Pythagorean 
(Carrick, 1985). Like earlier pronouncements, this oath (See Appendix A) 
did not directly address the concept of consent to treatment. It did contain, 
however, promises to "keep (the sick) from harm and injustice" and to 
"come for the benefit of the sick, remaining free of all intentional injustice." 
This concern for justice, although apparently not reflective of actual 
medical practice at the time, marked an important development in medical 
ethics. 
During the Roman Era, although the medical profession was certainly 
familiar with the Hippocratic tradition, little attention was paid to medical 
ethics. A notable exception was the influence of pagan humanism in the 
writings of popular medical theorists, such as Libanius (Polani, 1983). 
Even Galen (c. A. D. 138-201), the celebrated Roman physician and 
prolific author, left little written evidence of a concern with ethical practice. 
Interestingly, while few records exist of Roman concerns with overtly 
ethical medical issues, significant attention was paid to medical etiquette. 
Since formal medical training and certification of doctors would not be 
instituted in Italy for almost a thousand years, the maintenance of proper 
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professional behavior and decorum would allow patients to differentiate 
between sincere, dedicated physicians and charlatans, whose practice 
was often marked by braggadocio and flamboyant self-promotion. Thus, 
proper professional etiquette could be seen as an important way in which 
to address the ethical issue of development of trust between patient and 
medical practitioner. 
During the early Middle Ages, professional medicine in the Western 
world was often controlled by governmental decree. Concepts of ethical 
practice were beginning to appear but were still rudimentary in nature. In 
Italy, under the Ostrogoth Cassiodorus (c. A. D. 550), a small sense of 
physician/patient partnership was indicated by the governmental 
encouragement of patients to ask, and of their physicians to answer, 
appropriate medical questions (Smith, 1979). 
The concurrent development of medicine in the Arabic world was 
characterized by significant advancements in practical and scientific 
aspects but evidenced little expansion upon current, minimal, ethical 
precepts. Even the writings of Avicenna (c. A. D. 1000), arguably the 
greatest figure of Arabic medicine, showed minimal focus on medical 
ethics (Gutas, 1988). Medicine in the Arabic world was not devoid of 
ethical direction, however. Judaic ethicists were especially active during 
this period. Most notable was Moses ben Maimon (a.k.a. Maimonides, c. 
A. D. 1100) whose writings on the Law and morality (e.g., Maimonides, 
1956) laid important groundwork for later developments in Jewish medical 
ethics. 
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The late Middle Ages saw the emergence of the School of Medicine in 
Salerno, Sicily. The requirements of the Salernitan School, extensive 
formal education, public examination, and professional licensure, were 
endorsed and enforced by Pope Frederick II and subsequent pontiffs 
(Polani, 1983). While no significant changes in the ethical relationship 
between doctor and patient are attributable to this school, its rise to 
prominence permanently established the concept of rigorous professional 
training for physicians and established a framework for the inclusion of 
ethical professional requirements, such as informed consent to treatment. 
The Protestant Reformation heralded the beginning of a significant 
concern with ethics in Western philosophy. Although none of his 95 theses 
pertained to medicine, Luther exemplified the intense interest in questions 
of religion and personal morality that was manifested by philosophers and 
theologians in the early sixteenth century. The burgeoning cultural 
emphasis upon personal responsibility and individual freedom served to 
create a new view of the worth of the individual and gave form to the 
concept of autonomy as an inherent value of personhood. 
Seventeenth and eighteenth century philosophers continued a focus 
upon religious questions, most notably the Ontological Argument (the 
argument that the concept of God implies his existence), yet against this 
theocentric background, the perceived intrinsic value of humankind, and 
human thought, grew. Rationalists from Descartes (1596-1650) through 
Spinoza (1632-1677) to Leibniz (1646-1716) attempted to construct 
complete moral and metaphysical systems based upon logic and rational 
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argument (Coppleston, 1963). British empiricist Locke (1632-1704) 
condemned paternalistic concepts such as the divine right of kings, while 
Rousseau (1712-1778) argued for a social order which reflected 
humankind's basic goodness. Clearly, in eighteenth century Europe, the 
stage was set for a precise articulation of the ethical precepts governing 
human interaction. These precepts were enunciated by Immanuel Kant 
(1724-1804) who synthesized the Rationalism of Leibniz and the 
Skepticism of Hume into a deontological ethical system, the culmination of 
which was the Categorical Imperative; "...I ought never to act except in 
such a way that I can also will that my maxim should become a universal 
law" (Kant, 1964, p. 70). Most relevant to the concept of informed consent 
was the Practical Imperative, a special case of the Categorical Imperative 
which related to interpersonal behavior: "Act in such a way that you always 
treat humanity, whether in your own person or in the person of any other, 
never simply as a means, but always at the same time as an end" (Kant, 
1964, p. 96). 
Kant's affirmation of human worth implied the respect for individual 
dignity and autonomy upon which the concept of informed consent is 
based. Indeed, it has been argued that the primary function of informed 
consent is the maintenance of patient autonomy (Engelhardt and 
McCullough, 1981). 
The acceptance of a personal right of autonomy is the sine qua non of 
the doctrine of informed consent. The traditional Anglo-Germanic respect 
for individual privacy and autonomy influenced not only the writings of 
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Rousseau and Kant but also the development of the ethical stance of the 
Christian Church. Positing earthly life as sacred, but also as a precursor 
to a more important afterlife, Catholic ethical tradition has consistently set 
limits upon the "right" of physicians to encroach upon the autonomy of the 
individual in order to preserve mortal life (Sloane, 1983). In contrast, 
Jewish philosophy has maintained a focus upon earthly human life, 
considering it to be the ultimate expression of God's handiwork and, 
therefore, sacred and to be preserved at all costs (Jakobovits, 1983). 
Consequently, the right to refuse medically needed treatment has not 
usually been recognized in the Jewish tradition. This dialectic between 
Jewish paternalism and Christian individualism foreshadowed a similar 
tension in current medical ethics, which appropriately finds its focus in the 
concept of informed consent. 
Beauchamp and Childress (1979) have suggested that the modern 
health care professional must take into consideration several ethical 
concepts when considering professional action. Included in these 
concepts are: 
a) Autonomy: The right of individuals to determine their own course 
of action, in congruence with their own chosen plans. 
b) Nonmaleficence: The obligation not to harm people. 
c) Beneficence: The duty of persons to help others. 
d) Justice: The requirement that benefits, burdens, goods, and 
services be distributed equitably. 
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e) Informed consent: The right of the patient to have knowledge of 
and consent to a particular treatment before it is administered. 
The potential and inherent conflict among the first four of these 
concepts is most clearly evidenced in the actualization of informed 
consent. The paternalism often implied by beneficence may serve to limit 
patient autonomy. Nonmaleficence, similarly, may serve to limit to the 
patient disclosure of potentially injurious information, thereby diminishing 
autonomy. Conversely, full respect of patient autonomy could result in 
certain subpopulations selecting less effective treatments, thereby 
diminishing justice. 
Informed Consent as a Legal Doctrine 
Since the French enlightenment, Kant, and the subsequent progressive 
secularization of society, significant developments in health care ethics 
have been manifested most decisively in legal doctrine and legislation. 
Modern informed consent doctrine, while philosophically rooted in the 
concept of autonomy, developed directly from the common-law rule that a 
physician is subject to "liability in tort" to the patient for any unauthorized 
operation (Ludlam, 1978). Informed consent rulings in the United States 
were first seen at the beginning of the current century. Ludlam notes that 
early cases (e.g., Mohr v. Williams [1905], Pratt v. Davis [1906], Rolater v. 
Strain [1913]) found that unless a patient consented expressly or implicitly 
to a medical operation, the performance of such an operation would 
constitute an actionable act of battery by the physician. 
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In his decision on Schoendorff v. Society of New York Hospitals 
(1914)- in which a tumor was removed from a patient's abdomen without 
her consent- Judge Cardoza observed: 
"Every human being of adult years and sound mind has a right to 
determine what shall be done with his own body; and a surgeon who 
performs an operation without his patient's consent commits an assault, 
for which he is liable in damages...This is true, except in cases of 
emergency where the patient is unconscious, and where 
it is necessary to operate before consent can be obtained" (Quoted in 
Ludlam, 1978, p. 20). 
Subsequent legal decisions (e.g., Natanson v. Kline, 1960) enunciated 
the duty of the physician to warn the patient of potential risks of treatment. 
In Mitchell v. Robinson (1960) a similar duty to disclose risk was adjudged 
in a case regarding physical injuries suffered as a result of insulin shock 
treatments. While still primarily concerned with somatic injury, this case 
dealt with issues at the juncture of medical and psychiatric treatment and 
sen/ed as a harbinger of the eventual expansion of the informed consent 
doctrine to include psychiatric and psychological practice. As was 
exemplified in the recent case of Osherhoff v. Chestnut Lodge (Malcorn, 
1988), the courts clearly consider informed consent to apply to the 
provision of psychotherapy. 
Initially, courts found physicians to be responsible to disclose to 
patients the type and amount of information that a "reasonable medical 
practitioner" (Natanson v. Kline, 1960) would disclose or that would reflect 
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the common practice of competent physicians. This criterion came to be 
l<nown as the "professional standard." Current trends, however, are to 
impose a more rigorous standard of the scope of required information to 
be disclosed to the patient, encompassing all significant risks and relevant 
alternatives. Known as the "material risk" standard, this criterion was first 
articulated in Canterbury v. Spence (1972) and Cobbs v. Grant (1972). It 
is noteworthy that in moving from a profession-based standard to a 
consumer-based standard, the courts have acted to increase the 
perceived value of personal autonomy and have decreased the 
paternalistic options of health care professionals. 
The courts have held that in certain situations, physicians are fully or 
partially exempt from a "duty to disclose" risks to patients. Included in 
these are (Ludlam, 1978): 
a) Disclosure of minor or immaterial risks. (Holt v. Nelson, 1974) 
b) When the patient is already aware of the risk. (Canterbury v. 
Spence, 1972) 
c) When existence of the risk is "common knowledge." (Wilkinson v. 
Vesey, 1972) 
d) When the risk only results from improper performance of the 
medical procedure. (Mull v. Emory University, 1966) 
e) When the risk is not generally known to the profession at the time 
of the procedure. (Trogun v. Fruchtman, 1973) 
f) When the patient requests to not be informed. (Canterbury v. 
Spence, 1972) 
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e) In cases of medical emergency. (Canterbury v. Spence, 1972) 
h) In cases in which full disclosure would cause the patient's condition 
to worsen, physically or mentally. Known as "therapeutic privilege" 
(Salgo V. Leiand Stanford Jr. University Board of Trustees, 1957), this 
concept allows the practitioner to inform the patient less than fully, as 
long as there would be a clearly predictable injurious result of full 
disclosure and as long as the practitioner does not withhold information 
merely to assure the patients compliance with a particular treatment. 
In such cases, the physician's duty to "above all, do no harm" is held to 
supersede respect for the patient's autonomy. 
The Current Status of Informed Consent 
Originally conceived as pertaining to the therapeutic relationship 
between physician and patient, the applicability of the informed consent 
process has expanded over the past few decades to include most 
professional relationships between patients and professionals in the health 
care arena. 
The acceptance of an ethical mandate to provide informed consent is 
not universal, however. Physicians have been slow to endorse the 
concept, possibly concerned about an erosion of professional prerogative. 
Laforet (1976) brands informed consent as a "legalistic fiction that 
destroys good patient care and paralyzes the conscientious physician" 
(pp. 1584-1585), asserting that the integrity of the physician is the most 
effective safeguard of patient well-being. In a similar sentiment, 
Ingelfinger (1980) declares that "authoritarianism, paternalism, and 
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domination are the essence of the physician's effectiveness" (p. 135). In 
psychology, the potential incompatibility of fully informed consent with 
many therapeutic techniques has been noted (Widiger & Rorer, 1984). 
Several authors (e.g., Finney, 1987; Mahler, 1986; Trice, 1986a & b) have 
pointed out that fully informed consent in the research setting may unduly 
affect the validity of outcome data. 
Notwithstanding these objections, prior informed consent to 
participation in professionally mediated activities has become increasingly 
seen as the right of the individual. Ironically, medical associations have 
been reticent to include a right to informed consent-to-treatment in their 
codes of professional conduct. In its 1983 Declaration of Geneva (See 
Appendix B), the World Medical Association neglects to mention informed 
consent in particular, or patients' rights in general, although a pledge of 
confidentiality is included in this update of the Hippocratic Oath. The 
American Medical Association, on the other hand, specifies in its 
Principles of Medical Ethics (See Appendix C) that physicians "shall 
respect the rights of patients," although these rights are not enumerated. 
The American Hospital Association has been more proactive on the 
subject of patients' rights, however. In its 1973 Patient Bill of Rights (See 
Appendix D), the right of a patient "to receive from his (sic) physician 
information necessary to give informed consent..." is clearly asserted. 
Interestingly, the apparent reticence of the community of physicians to 
embrace informed consent as it applies to medical treatment is not evident 
in the areas of medical research and experimentation. Perhaps as a 
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reaction to tlie horrors of Nazi medical experimentation during World War 
II, a clear consensus has emerged regarding the necessity for truly 
voluntary and informed subject consent to medical research. 
The earliest formal reaction to Nazi "research" atrocities came as a set 
of standards for medical research behavior, embedded within a judgment 
against a group of German doctors at the War Crimes Tribunal in 
Nuremberg, Germany in 1947. Known as the Nuremberg Code (See 
Appendix E), its initial, and most strident, statement is that "the voluntary 
consent of the human subject is absolutely essential." In its Declaration of 
Helsinki (See Appendix F), the World Medical Association asserts a similar 
requirement for the physician to obtain prior voluntary consent from the 
research subject, although it allows for the possible omission of informed 
consent procedures in some instances in which research is combined with 
professional care. 
PsvcholoQv and Informed Consent 
Informed Consent and Psychological Treatment 
The mandate for ethical psychological treatment developed as an 
expansion of ethical requirements for psychiatric treatment, which in turn 
developed from ethical requirements for medical treatment. This 
developmental process was rather slow, however, and it was not until 
1951 that the American Psychological Association published its first 
Ethical Code for clinical and consulting psychologists. The current version 
of "Ethical Principles of Psychologists of the American Psychological 
Association" (1989) reflects the increased concern of the profession over 
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issues of consumer rights, including the right to prior informed consent 
(Nagy, 1988). Principle 6, titled "Welfare of the Consumer," states, 
"Psychologists fully inform consumers as to the purpose and nature of an 
evaluative, treatment, educational, or training procedure, and they freely 
acknowledge that clients, students, or participants in research have 
freedom of choice with regard to participation" (American Psychological 
Association, 1989, p. 393). 
In August, 1992, the Council of Representatives of the American 
Psychological Association adopted a revised "Ethical Principles of 
Psychologists and Code of Conduct", which will take effect December 1, 
1992 (American Psychological Association, in press). This newly revised 
codification of professional principles delineates much more specifically 
than the 1989 "Principles" the concern of the Association that clients be 
afforded opportunity for appropriate prior consent. Section 4.02(a), 
"Informed Consent to Therapy", specifically states "Psychologists obtain 
appropriate informed consent to therapy or related procedures, using 
language that is reasonably understandable to participants." 
Ethical codes for counselors (American Association for Counseling and 
Development, now the American Counseling Association, 1988), 
psychiatrists (American Psychiatric Association, 1986), marriage and 
family therapists (American Association of Marriage and Family Therapy, 
1985), and social workers (National Association of Social Workers, 1979) 
all speak to the need for provision of informed consent. 
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In Making health care decisions: A report on the ethical and legal 
implications of informed consent in the patient-practitioner relationship 
(1982), the President's Commission for the Study of Ethical Problems in 
Medicine and Biomedical and Behavioral Research recommends the 
provision of informed consent in all but a very limited category of treatment 
interactions, including a recommendation of informed consent for 
psychological treatment. 
Writers have noted the overwhelming ethical (Coyne, 1976; 
Handlesman, Kemper, Kesson, McLain, & Johnsrud, 1986; Hulteng, 1988) 
and legal (Epstein, Steingarten, Weinstein, & Nashel, 1977; Noll, 1976; 
Sadoff, 1974) arguments for the provision of informed consent in 
psychotherapy. Especially in light of the increasing use of deception 
(paradox) in psychotherapy, the importance of the provision of informed 
consent to treatment has become a major ethical and legal focus (Brown & 
Slee, 1986; Henderson, 1987; Martin, 1986). Failure to provide adequate 
informed consent to treatment exposes the psychotherapist to 
considerable risk of litigation (Bray, Shepherd, & Ray, 1985; Malcolm, 
1986; Pope, Simpson, & Weiner, 1978). The mandate to provide a 
consent opportunity is seen as extending to include mental patients 
(Meisel, 1983; Schwitzgebel, 1975) and children (Glenn, 1980), although 
Kaser-Boyd and her associates (Kaser-Boyd, Adelman, Taylor, & Nelson, 
1986) have suggested that in the case of children, determinations of 
competency to consent be based upon the capacities of the child. Some 
therapists (Jensen, Josephson, & Frey, 1989) have even begun to use the 
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informed consent procedure as a method to establish trust and deflect 
clients' resistance to therapy. 
Informed Consent and Psychological Research 
For most of the recorded history of psychological thought, "informed 
consent to participation in psychological research" was a phrase with little 
meaning. Traditionally, psychology was an aspect of philosophy, and was 
speculative in nature. The gradual "scientification" of psychology was 
heralded by the publishing of Elements der Psychof^ysik by Gustav 
Fechner in 1860, a treatise concerned with the measurement of sensory 
experiences. The focal point of the foundation of psychology as an 
experimental science came in 1879 with Wilhelm Wundt's establishment of 
the first laboratory of psychology at the University of Leipzig. Recognizing 
the pivotal importance of Wundt's work, Titchener (cited in Klein, 1970) 
referred to Wundt as not only the founder of experimental psychology, but 
of psychology itself. 
Yet, even with the development of Wundt's laboratory, "informed 
consent" remained irrelevant in experimental psychology. The 
introspective method championed by Wundt and his followers involved 
trained observers reporting upon simple mental processes they observed 
in themselves. Thus, the experimenters were their own subjects, 
rendering consent to participate a moot point. 
With the rise of behaviorism, introspection gave way to more objective 
scientific observation in the laboratory and the field. While the concept of 
informed consent to participation now became applicable, little attention 
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was actually paid to obtaining it. A review of some of the major works on 
the history of scientific psychology (Klein, 1970; Hearst, 1979; Reisman, 
1976) yielded no references at all to the concept of informed consent. 
As the incorporation of deception in psychological research 
increased, the need for informed consent bacame more apparent. 
Participation in research could no longer always be considered innocuous 
and without risk. The "post-experimental stress disorder" experienced by 
many of the participants in Milgram's studies of obedience (1963) was of 
concern to many professionals. Zimbardo (1975) stopped a simulated 
prison experiment after only 6 of a planned 14 days, after several 
instances of depression, extreme anxiety and psychosomatic illness 
occurred in the subject group. Gradually, the concept of providing 
potential subjects of psychological research an informed decision on 
participation has gained ground both legally and in professional ethics.The 
Belmont report (National Commission for the Protection of Human 
Subjects of Biomedical and Behavioral Research, 1978) recommended 
the provision of informed consent to participants in research. The Federal 
Policy for the Protection of Human Subjects (U. S. Department of Health 
and Human Services, 1991) implemented that recommendation as part of 
Federal Law. The current version of the Ethical Principles of 
Psychologists of the American Psychological Association (1989) 
addresses the need for informed consent in research through Principle 9d. 
"...The investigator informs the participants of all aspects of the research 
that might reasonably be expected to influence willingness to participate 
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and explains all other aspects of the research about which the participants 
inquire" (American Psychological Association, 1989, p. 394). The 
upcoming revision of the "Principles" (American Psychological Association, 
in press) delineates this requirement even more clearly. Section 6.11 (a), 
"Informed Consent to Research", specifies "Psychologists use language 
that is reasonably understandable to research participants in obtaining 
their appropriate informed consent." 
A decade prior to the implementation of current Federal guidelines on 
informed consent, Kimmel (1979) noted with concern the steady increase 
in governmental regulation of human subjects research. The increasing 
expectancy that informed consent will be provided to potential subjects 
has been resisted by some researchers, especially those involved in 
research which utilizes deception. Several writers (Dill, Gilden, Peter, & 
Hanselka, 1982; Finney, 1987; Trice, 1987) have asserted that the 
provision of informed consent to participants, especially in studies of 
subject reaction to experimentally induced stressors, has a significant 
effect upon subject performance. Other authors (Wiener & Erker, 1986) 
contend that, in studies involving deception, results are unaffected by the 
provision of informed consent. Oliansky (1991) has argued that the use of 
deception itself is unethical and impractical in most research situations, 
while Christensen (1988) asserted that participants in studies involving 
deception didn't mind being deceived or having their privacy violated and 
actually enjoyed the research experience more than participants in non-
deceptive research. 
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Trice (1986a) informed a group of student volunteers of a withdrawal-
without-prejudice policy, a few days before a planned meeting. He found 
that significantly fewer members of this group showed up for the meeting 
and stayed for testing than subjects who were informed of the policy at the 
time of the meeting, immediately prior to testing. 
Smith (1976) foresaw these difficulties and suggested that some 
research designs are incompatible with fully informed consent. Linsey 
(1984) suggested that it is the task of the profession to create new and 
innovative research designs which will allow for the protection of subjects' 
rights, including the provision of informed consent. Addressing this issue, 
Brod and Feinbloom (1990) designed a standardized verbal consent 
procedure which provided adequate information to geriatric subjects for a 
truly informed consent decision, while at the same time avoiding the high 
refusal rates often seen with geriatric subjects when written consent is 
required. 
Overall, the provision of prior informed consent for both treatment and 
research participation has become the standard of practice, both ethically 
and legally. Actual professional behavior, however, may often fail to 
achieve that standard. Malcom (1988) has noted that many physicians 
consider the concept to be "an unworkable myth" (p. 59). In her doctoral 
dissertation, Witkin (1985) found that applied psychologists often decided 
to withhold information from therapy clients and had only a superficial 
awareness of the ethical ramifications of their actions. In a review of 
studies published in nine social psychology journals, Adair, Dushenko, and 
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Lindsay (1985) found ttiat the proportion of studies that reported obtaining 
informed consent from subjects was negligible. While the Court, major 
professional organizations, and the public at large (President's 
Commission for the Study of Ethical Problems in Medicine and Biomedical 
and Behavioral Research, 1982) have the expectation that the autonomy 
of consumers will be respected through the provision of informed consent 
procedures, that expectation has yet to be fulfilled. 
Informed Consent in the Treatment of Alcoholism 
As noted above, provision of fully informed consent has been seen to 
be an ethical imperative in both the treatment of research subjects and the 
provision of clinical services. Pragmatic difficulties, however, are 
sometimes encountered in the application of this ethical and legal 
mandate. Complications may arise from idiosyncratic characteristics of 
certain subject or client populations. Chronic alcoholics constitute an 
example of a population with whom the provision of informed consent is 
potentially complicated by recipient characteristics. 
Of the various therapeutic interventions offered to the public by the 
health-care community, inpatient/residential treatment for alcoholism is 
one of the most all-encompassing and psychologically intrusive. Such 
treatment incorporates psychotherapy, medical and pharmacological 
management, and behavior modification techniques to effect significant 
change in deeply embedded addictive behaviors. Participants are 
encouraged to adopt major, permanent changes in most aspects of their 
lifestyles. Programs usually provide treatment and supervision on a 24 
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hour basis for a period of a few weeks to several months in duration. The 
average length of stay in inpatient treatment has shortened in recent 
years, subsequent to reimbursement limitations imposed by third party 
payers. Inpatient treatment lasting only 21 days is rapidly becoming 
commonplace, although traditional 4 week programs abound. In 
consideration of the intensity and duration of this type of treatment, little 
question exists as to the ethical and legal imperative for the provision of 
informed consent to treatment. 
Ironically, participation in this all-encompassing medico/psychological 
intervention is seldom truly voluntary. Patients often enter treatment as a 
result of court order, family pressure, or employer ultimatum. A commonly 
held opinion among addiction professionals is that no one enters treatment 
voluntarily, but that every patient has been "forced" into treatment by the 
environmental and personal results of their addictive behaviors. Thus, 
patients in alcoholism treatment can be considered to possess limited 
autonomy as a result of their prior addictive behaviors. As Dyer (1982) 
has noted, however, limited autonomy implies neither limited competency 
nor a limitation on the patient's right to self determination within the context 
of environmentally imposed constraints. The provision of informed 
consent to treatment, including an appraisal of the risks and benefits of 
both consent and refusal, would appear to be indicated in such cases of 
limited autonomy. 
Valid informed consent consists of three elements: information, 
voluntariness, and competency (National Commission for the Protection of 
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Human Subjects of Biomedical and Behavioral Research, 1978). 
Information, meaningful data presented to the patient, and competency, 
the ability of the patient to make a personally valid treatment decision, 
interact in the function of comprehension, the patient's understanding of 
proffered information. Limitations of rationality or cognitive complexity do 
not in themselves bespeak limitations in the patient's competency for 
treatment decisions (Dyer, 1982). They do, however, limit the patient's 
ability to understand consent information. If that information is presented in 
a manner which is unintelligible, or otherwise noncommunicative, to the 
patient, comprehension will be similarly limited and the consent process 
will lack validity. The mere presentation of a consent form, with no 
provisions to insure comprehension of the information by the patient, may 
constitute no more than a legalistic exercise (Brady, 1979). In a survey of 
adult patients in a chemical dependency treatment program. Mills (1990) 
found not only that recall for the content of consent forms was poor, but 
that approximately half of the respondents reported never reading the 
forms in the first place. Levine (1984) has asserted that the principle of 
distributive justice requires that special protection be provided to those 
who are relatively incapable of protecting their own interests in the 
informed consent process. He suggests that comprehension of consent 
information can be increased by either limiting the subject pool to the most 
intelligent or by introducing procedures to enhance the comprehensibility 
of consent information. Limitation of subject pool is not a viable option, 
however, in the treatment setting. Therefore, enhancement of 
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comprehensibility of consent information would appear to be the 
appropriate means to increase comprehension in situations in which a 
significant proportion of the subjects (or patients) experience a limitation of 
their ability to understand customarily presented information. 
Cognitive Impairment in Chronic Alcoholics 
There is evidence that alcoholics in treatment constitute a population 
who, because of their higher than average potential for cognitive 
impairment, could experience difficulty in comprehending consent 
information as customarily provided. 
Voluminous data exist to evidence significant cognitive compromise in 
chronic alcoholics. Impairment has been found in abstract 
conceptualization (Parsons, 1987a, 1987b: Pishkin, Lovallo, & Bourne, 
1985; Svanum & Schladenhauffen, 1986), attention (Oskar-Berman, 
1987), problem solving (Acker, Ron, Lishman, & Shaw, 1984; Parsons, 
1987a, 1987b; Svanum & Schladenhauffen, 1986), visuospatial integration 
(Butters & Brandt, 1985; Goldman, Williams, & Klisz, 1983; Oskar-
Berman, 1987; Parsons, 1987a, 1987b; Svanum & Schladenhauffen, 
1986), new learning (Butters & Brandt, 1985; Parsons, 1987a, 1987b; 
Svanum & Schladenhauffen, 1986), and information processing (Cermak 
& Butters, 1973). 
Impairment in short term visual memory has been noted by several 
researchers (Donat, 1986; Markowitsch, Kessler, & Denzler, 1986; Ryan & 
Lewis, 1988; Salmon, Butters, & Schuckit, 1986). While some authors 
assert that similar deficits in short term verbal memory are apparent 
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(Cermak, 1987; Ryan & Lewis, 1988), most (Butters & Brandt, 1985; 
Donat, 1986: Grant, Adams, & Reed, 1979) suggest that verbal encoding 
remains resistant to change and that findings of impaired short term verbal 
memory in chronic alcoholics are confounded by factors of cognitive 
clouding and visuointegrative compromise. 
Alcoholism treatment programs usually begin with a short, 2-3 day, 
detoxification period for most patients (McCrady, 1987). Informed consent 
is seldom requested from acutely intoxicated individuals because of the 
obvious disruption of cognitive processes during intoxication. The acutely 
intoxicated patient experiences confusion (Lex, Greenwald, Lukas, & 
Slater, 1988) and significantly impaired short term memory (Mello, 1973), 
including both registration and recall. 
During the withdrawal period, patients experience clouding of the 
sensorium, disturbance of consciousness, anxiety, mood disturbances, 
and various somatic symptoms (Gross & Lewis, 1973). 
Malloy, Noel, Rogers, Longabaugh, and Seattle (1989) have noted the 
negative treatment implications of severe neuropsychological impairment 
and have suggested that in such cases early placement in a supervised 
living setting may be more efficacious than intensive substance abuse 
treatment. For the majority of patients, however, the degree of 
neuropsychological impairment experienced serves to handicap, rather 
than to eliminate, their capacity to benefit from treatment. Most treatment 
programs wait until the patient has progressed beyond the initial 
detoxification period before initiation of the formal informed consent 
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process for the full treatment regimen. It is questionable, however, that 
the patient is able at this point to adequately comprehend customarily 
presented consent information. While the overt signs of acute intoxication 
are no longer apparent during the immediate post detoxification period, the 
data strongly suggest that chronic alcoholics at this stage are experiencing 
severe compromise of cognitive function (Claiborne & Greene, 1981 ; 
Parsons, 1987a, 1987b). Vocabulary level does not appear deteriorated 
(Goldman, 1987), a finding which may explain the appearance of reading 
in the absence of true comprehension. Clouding of consciousness, 
concentration difficulties, visuoperceptual impairment, visual and verbal 
learning impairments, and memory defects may all be experienced by the 
recently detoxified chronic alcoholic (Ellenberg, Rosenbaum, Goldman, & 
Whitman, 1980; Kish, Hagen, Woody, & Harvey, 1980). Ellenberg and 
associates suggest that both verbal and visuospatial learning evidence 
significant recovery within two weeks, although visuospatial impairment 
may last longer in long term alcoholics. Within three weeks, Kish and 
associates note recovery of function in short term memory and attention, 
visuospatial analysis/synthesis, abstract thinking, visual memory, and 
serialization ability. Goldman (1983) states that deficits in verbal learning 
appear to remit as early as one month after detoxification, although 
Yohman, Parsons, and Leber (1985) found significant differences between 
alcoholics and controls on verbal, abstracting/problem solving, and 
perceptual motor tasks at seven weeks after detoxification. At 13 months 
they noted no difference between controls and alcoholics on verbal tasks. 
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Brandt, Butters, Ryan, and Bayog (1983) similarly found performance on 
several tests of neuropsychological function to be significantly better for 
alcoholics with long term sobriety (> 5 years) than for those with 
intermediate (1-3 years) and short-term (1-2 months) sobriety. 
Although several authors have noted some recovery over time of 
cognitive function in abstinent alcoholics, provision of a protracted (2-4 
week) detoxification period prior to the initiation of the consent process is 
not a workable option for alcoholism treatment centers. Neither is limiting 
sendees to alcoholics who have been sober for one month prior to entering 
treatment. A viable alternative, therefore, would appear to be modification 
of informed consent procedures in order to enhance comprehension of 
salient information by prospective patients, despite their potential cognitive 
limitations. 
Comprehension of Consent Information 
Written Consent Forms 
Perhaps as a response to ever-increasing documentation requirements 
in both research and treatment settings, utilization of a written consent 
form, containing an enumeration of salient information along with a 
signature line upon which the subject/patient may indicate consent, has 
become standard practice. Often, however, signatories do not understand 
major portions of that to which they have consented (O'Connor, 1981 ; 
Silva & Sorrell, 1984,1988). Several stimulus variables affect the 
comprehensibility of these forms, especially as administered to recently 
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detoxified alcoholics, including: vocabulary difficulty, familiarity, readability, 
textual coherence, schema, and redundancy. 
The most basic variable affecting text comprehensibility is vocabulary 
difficulty. If readers are unaware of the meaning of constituent words, they 
are less likely to understand the attempted communication. 
Comprehension does not manifest a simple inverse proportionality to 
vocabulary difficulty, however. While word understanding is important for 
text understanding, simplifying vocabulary significantly below a reader's 
functional level does not necessarily increase comprehensibility over text 
written at his or her vocabulary level. For example, for a subject with a 
seventh grade vocabulary, text written with a second grade vocabulary 
would not necessarily be more comprehensible (i.e., would not more 
effectively communicate information) than text written with a sixth grade 
vocabulary. In fact, such oversimplification of wording could diminish the 
complexity of information communicated. Additionally, vocabulary 
simplification would not appear to differentially enhance comprehension by 
chronic alcoholics, as compared to normals, since vocabulary function 
appears resistant to compromise in long-term drinkers (Goldman, 1987). 
Freebody and Anderson (1983) point out that familiarity accounts for 
almost three times as much variance in comprehension as vocabulary 
level. If the concepts presented in the text have been encountered before, 
the reader is likely to manifest a higher level of understanding than when 
confronted with unfamiliar concepts and terminology. While it is not 
possible in the clinical setting to control for prior exposure to consent-to-
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treatment information, it is possible to avoid specialized terminology and 
parochial usage of othenvise familiar phrases. As with vocabulary, 
differential enhancement of understanding for chronic alcoholics would not 
be expected. 
"Readability" has often been seen as a function of word length (in 
syllables), sentence length, and word familiarity. Several studies (e.g.. 
Baker & Taub, 1983; Grundner, 1980; Morrow, 1980) have substantiated 
the high level of reading difficulty presented by typical informed consent 
forms utilized in the provision of health services and health research. 
Eaton and Holloway (1980) observed increased comprehension of patient 
information materials written at a fifth grade reading level as compared to 
materials written at a tenth grade level. Similarly, Tymchuk, Ouslander, 
and Rader (1986) found that comprehension by elderly subjects of a list of 
client rights was significantly higher for a simplified written version than for 
the version of standard difficulty. 
Anderson and Armbruster (1986) assert that the "textual coherence" of 
written communication is the most important contributor to 
comprehensibility. Emphasizing the structural aspects of text, they 
suggest that by presentation of data within commonly accepted and 
familiar structural formats (e.g., listings, comparisons, temporal 
sequences, cause/effect relationships, etc.) comprehension is enhanced. 
Explicitly "signaling the structure" (p. 155) is suggested, including 
introductory statements, summary statements, pointer words, and textual 
cues, such as underlining. Clarification of structure would appear to be 
31 
especially beneficial to the cognitively clouded, recently detoxified 
alcoholic. 
Another important characteristic of comprehensible text is the early 
presentation of a "schema": a meaningful context for the facts presented 
subsequently. Wilson and Anderson (1986) suggest that a schema is a 
conceptual structure that provides "slots that can be instantiated with 
specific information from a text" (p. 33). In the absence of a meaningful 
conceptual framework, the text presents merely "data" which only 
becomes comprehensible information as a meaningful interrelationship is 
developed by the reader. The clouded consciousness and impaired 
concentration experienced by recently detoxified alcoholics (Ellenberg et 
al., 1980; Oscar-Berman, 1987; Kish et al., 1980) reduce the ability of 
these readers to independently derive schema. Initial, clear presentation of 
schema would, therefore, appear to enhance comprehensibility of text for 
all readers, but especially for cognitively impaired, recently detoxified 
alcoholics. 
Several theorists (Just & Carpenter, 1980; LaBerge & Samuels, 1974; 
Miller & Kintsch, 1980) emphasize that immediate memory capacity is a 
major determinant of text comprehension. Schwartz (1984) has 
suggested that poor readers have difficulty maintaining information in 
short-term memory. An implication of these findings is that strategies 
which facilitate immediate memory function may enhance comprehension. 
Adams (1982) offers tangential support of this concept by noting that 
highly coherent text offers many more sources of redundancy than less 
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coherent text. As has been indicated previously, attention and immediate 
memory function often appear impaired in recently detoxified alcoholics. 
Provision of multilevel redundancy of information in consent procedures 
may increase comprehension for this population. 
One method which provides redundancy is repeated exposure to the 
same material. Miller and Wlllner (1974) suggested that subsequent to 
reading the consent information, patients complete a short quiz on its 
content. If answers to the quiz demonstrated an inadequate 
comprehension of the material, remedial action could be taken, including 
discussing the missed items with the subject or requiring them to reread 
the consent form. Taub and Baker (1983) utilized the second option in 
their study of the effect of repeated testing upon the comprehension of 
informed consent materials by elderly subjects. Essentially a mastery 
level teaching paradigm, each subject read a sheet of consent information, 
then completed a short quiz. If any quiz items were missed, the subject 
was tutored on the answers to those particular items and the quiz was 
subsequently readministered. If the subject again missed any items, the 
process was repeated. If after three administrations of the information 
sheet the subject still was unable to answer all quiz items correctly, he or 
she was considered to be unable to understand the information presented. 
They found that this multitrial approach was effective in increasing 
comprehension of informed consent information in elderly volunteers. 
Congruent with earlier work (Taub, Kline, and Baker, 1981), it was noted 
that while comprehension was enhanced for subjects at all levels of 
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vocabulary proficiency, subjects witli higher fluency evidenced higher 
comprehension than those with lower fluency. 
The method of repeated administration appears effective in increasing 
memory for presented material, however it does not address the 
comprehensibility, as such, of the initial presentation of consent 
information. Taub and Baker (1983) admit that test repetition measures 
"rote learning rather than actual understanding (p. 137), but point out that 
it is doubtful that subjects are "capable of providing informed consent if 
they cannot find the correct answers after repeated testing and feedback." 
A major drawback of this technique in the clinical setting, however, is the 
considerable amount of staff and patient time involved in repeated 
administration and testing. 
Video Presentation 
Another potentially effective method of presentation of consent 
information is video. Similar to printed consent forms, videotaped 
presentation is.standardized across subjects and requires much less staff 
time than individual tutorial sessions. Through the use of videotaped 
lectures/presentations, salient information can be presented audibly to 
subjects, avoiding the potentially confounding effects of reading 
impairments. 
Although video presentation would appear to potentially enhance 
comprehension of consent information in poor readers, and thereby 
increase overall comprehension in an impaired population, Tymchuk, 
Ouslander, and Rader (1986) found that video presentation alone did not 
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significantly differ in effectiveness from standard written text presentation 
of Patient Rights information for a normal elderly population. The 
implication of their findings was that a change in presentation format, from 
print to video, did little to increase comprehension, notwithstanding the 
circumvention of any impediment to understanding caused by impaired 
reading abilities. Their findings may not be generalizable to recently 
detoxified, nonelderly, alcoholics, however. While some researchers have 
likened the cognitive impairments experienced by chronic alcoholics to 
those found in an elderly population ( the "premature aging theory"; 
Markowitsch, Kessler, and Denzler, 1986), most have recognized the 
cognitive impairments which accompany chronic alcohol abuse to be more 
numerous and of greater severity than the concomitants of normal aging 
(Svanum and Schladenhauffen, 1986). 
Barbour and Blumenkrantz (1978) asserted that when presented in 
addition to the standard written consent form, an informative videotape 
facilitated the achievement by patients of an adequate level of 
understanding of consent information. Such an additive presentation 
afforded not only substantial redundancy of exposure but also 
communicated an enhancement of meaningful structure into which the 
pertinent consent data could be fit. 
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PURPOSE 
Rationale for Present Study 
It appears that chronic alcoholics would benefit from many of the same 
modifications of standard informed consent presentations as the normal 
population, including simplified vocabulary level, avoidance of jargon, and 
enhanced readability. Presentation of the information in a meaningful 
context, utilizing commonly understood structural forms, would be seen as 
an effective aid to comprehension for all subjects, but especially for those 
experiencing some degree of cognitive clouding. 
In consideration of the significant impairment of attention, 
concentration, and short term memory which has been noted in recently 
detoxified alcoholics, it is suggested that an increase in information 
redundancy would significantly increase comprehension of consent 
information in that subject group. To test this, a sample of chronic 
alcoholics recently admitted to treatment was presented with standard 
research consent information, varying among subjects in the amount of 
redundancy of salient information. 
The emergence of the written consent form as the primary mode of 
consent information presentation occurred prior to the development and 
proliferation of video cassette recording. This new technology allows 
presentation of consent information in a manner which more closely 
approximates the ideal of a face to face tutorial than the standard written 
consent form. Video presentation can provide the image of a presenter 
along with the personalizing touch of a human voice. Additionally, video 
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lecture presentation of consent information eliminates the potential 
confounding effect of impaired reading ability in subjects. To test the 
effect of presentation mode upon comprehension of consent information, 
information was presented in two formats: a printed consent form and a 
videotaped lecture. Level of information redundancy varied as follows: 
1 Simple informed consent presented. 
2 Informed consent with enhanced redundancy presented. 
The printed consent form was written at the seventh grade reading 
level, utilized familiar structural formats in order to enhance textual 
coherence, and avoided the use of jargon and specialized terminology. 
Two levels of written consent information were utilized: 
1) Simple written consent information. 
2) Simple written consent information with an illustrative elaboration 
following each element of consent information. 
The video conditions consisted of short presentations in which the 
presenter answered questions from an off-camera voice by stating 
verbatim elements of consent information from the printed form. Two 
levels of video consent information were presented: 
1) Simple video consent information. 
2) Simple video consent information with an illustrative elaboration 
following each element of consent information. 
This study was a 2 X 2 complete factorial experiment (format [printed, 
video] X redundancy [single, enhanced]) with equal cell size. A 
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randomized group design was used, with 20 participants for each 
treatment. (See Figure 1.). 
Subsequent to presentation of the experimental level and type of 
consent information, subjects completed a short written quiz to assess 
their comprehension of the information. 
FORMAT 
R SIMPLE SIMPLE 
E 
D PRINTED VIDEO 
U 
N 
D 
A ENHANCED ENHANCED 
N 
C PRINTED VIDEO 
V 
Figure 1. Experimental design 
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The content of the basic elements of informed consent presented in the 
various formats and levels of redundancy fulfilled all pertinent ethical and 
statutory requirements, including regulations promulgated by the U. S. 
Department of Health and Human Services (1991, pp. 28016-28017). 
While the actual consent information presented pertained to the proposed 
research study, and not to the chemical dependency treatment experience 
itself, it is felt that the findings of this study will generalize readily to the 
presentation of both research and clinical consent information and will help 
both researchers and clinicians design more efficient and effective consent 
procedures for cognitively impaired individuals. 
Hypotheses 
The following hypotheses were advanced: 
Hypothesis 1 : Enhanced redundancy of presented information will result 
in a higher level of comprehension of the material, as reflected in a higher 
score on the Comprehension Quiz, than unitary presentation of the 
information (Simple condition). 
Hypothesis 2: Video presentation of the stimulus information will result 
in a higher level of comprehension of the material, as reflected in a higher 
score on the Comprehension Quiz, than presentation via a printed format. 
Hypothesis 3: Enhanced redundancy of presented information will result 
in a higher level of recall of the material, as reflected in a higher score on 
the Comprehension Posttest, than unitary presentation of the information 
(Simple condition). 
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Hypothesis 4: Video presentation of the stimulus information will result 
in a higher level of recall of the material, as reflected in a higher score on 
the Comprehension Posttest, than presentation via a printed format. 
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METHOD 
Subjects 
The stimulus conditions were presented to a total of 105 subjects. Of 
that number, 12 declined without comment to continue after reading or 
viewing the consent information. Another 4 subjects terminated 
participation, stating that they felt the process would take up too much of 
their time. Three subjects quit without comment after beginning the 
Questionnaire. One subject quit when he discovered that he was unable 
to read the Questionnaire. 
Of the remaining 85 subjects, 3 were deleted from the study because 
of WRAT-R reading subtest scores below the seventh grade level. In 
order to balance cells for gender, one Simple Video female subject and 
one Enhanced Printed male subject were randomly deleted from the 
study, leaving 4 equal cells of 20 subjects each, with 15 males and 5 
females in each cell. 
Sixty males and twenty females were included in the data set, with a 
mean age of 29.91 (s. d = 7.99), a mean level of educational attainment of 
12.68 years (s. d. = 1.99, when attainment of a G. E. D. is held equivalent 
to high school graduation) and a mean reading level of second semester 
of 11th grade. 
Volunteers were recruited from among clients in their first 21 days of 
inpatient or intensive outpatient treatment for alcohol, or alcohol and other 
drug, dependency. All volunteers were enrolled in treatment at one of five 
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Central Iowa chemical dependency treatment programs (Appendix G) 
Subjects were 18 to 53 years old, inclusive, had maintained at least 72 
hours of continuous sobriety prior to participation, and had completed any 
pharmacologically based detoxification prior to participation. Subjects with 
significant hearing loss or visual impairment were excluded from 
participation. Information on hearing loss and visual impairment was 
obtained both informally from the subject and from medical records 
available in the treatment setting. Demographic information for the sample 
is presented in Tables 1 and 2. 
Subjects were seen either individually or in a small group setting for 
testing, which lasted a half hour or less. The stimulus/testing paradigm 
was essentially administered individually, even in the small group setting. 
Administration of the stimulus and the testing procedures were identical in 
both individual and group administrations. No interaction among subjects 
occurred during the sessions. 
Research (Taub, 1979; Taub, Kline, & Baker, 1981) suggests individual 
vocabulary facility and years of education to be potent variables in 
predicting subject comprehension of informed consent material. Taub, 
Kline, & Baker (1981) have asserted that those with low vocabulary and 
little education may require special methods of informed consent. 
Potential subjects in this study were screened to assess their level of 
vocabulary function. All participants were administered the Reading 
subtest of the Wide Range Achievement Test - Revised (WRAT-R) (Jastak 
& Wilkonson, 1984). Since the stimulus material was written at the 
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Table 1. Age of subjects 
Age Frequency Percent 
18 3 3.8 
19 3 3.8 
20 4 5.0 
21 5 6.3 
22 3 3.8 
23 4 5.0 
24 1 1.3 
25 2 2.5 
26 3 3.8 
27 5 6.3 
28 2 2.5 
29 6 7.5 
30 3 3.8 
31 5 6.3 
32 1 1.3 
33 5 6.3 
34 4 5.0 
35 2 2.5 
36 3 3.8 
37 4 5.0 
38 3 3.8 
39 1 1.3 
40 1 1.3 
41 1 1.3 
42 1 1.3 
43 1 1.3 
47 1 1.3 
48 1 1.3 
51 1 1.3 
53 1 1.3 
Total 80 100.0 
Mean 29.91 Median 29.00 
Mode 29.00 Std dev 7.99 
Minimum 18.00 Maximum 53.00 
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Table 2. Years of formal education of subjects 
Yearsa Frequency Percent 
9 4 5.0 
10 8 10.0 
11 9 11.3 
12 23 28.8 
13 6 7.5 
14 16 20.0 
15 3 3.8 
16 11 13.8 
Total 80 100.0 
Mean 12.68 
Mode 12.00 
Minimum 9.00 
Median 12.00 
Std dev 1.99 
Maximum 16.00 
a Actual years of formal education completed are listed for the 17 
subjects who earned a G E. D. 
seventh grade level of difficulty, subjects scoring below seventh grade 
reading proficiency were excluded from the study. 
Similarly, subjects were asked their level of educational attainment. 
Those subjects who had completed fewer than 7 grades of formal 
education, not including special programming for learning impaired 
students, were excluded from the study. (Completion of a certificate of 
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General Educational Development was considered the equivalent of 12 
years of formal education.) 
Stanley, Guido, Stanley, and Shorten (1984) found that elderly patients 
(62 years of age and older) demonstrated significantly poorer 
comprehension of consent information than a younger (average 
age = 33.7 years) sample of patients. They concluded that geriatric 
patients may exhibit some impairment in their competency to give 
informed consent. Similar results were obtained by Taub, Baker, and 
Sturr (1986) who noted that comprehension of informed consent material 
seemed to vary directly with education and inversely with age. They noted 
an especially low comprehension rate among elderly patients with little 
education. In order to control for the effects of age on assessed 
comprehension in the current study, participation was limited to clients 
aged 18 to 61 years, inclusive. 
Procedure 
Overview 
All subjects were presented with consent information about the study 
through one of the four stimulus conditions: Simple Printed (SP), Simple 
Video (SV), Enhanced Printed (EP), or Enhanced Video (EV). Each 
subject then completed a short demographic questionnaire, a quiz over 
the content of the consent information, and was administered the Reading 
subtest of the WRAT-R. One week later, subjects were again 
administered the quiz over the content of the consent information. 
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Randomization of Condition 
Subjects were assigned to treatment conditions througli the use of a 
random drawing procedure. Tol<ens of identical size and shape were 
marked to indicate each of the specific treatment conditions. Twenty 
tokens of each condition were placed into an envelope marked "Males", 
yielding a total of 80 tokens in the container. An additional twenty tokens 
of each condition were placed into an envelope marked "Females". After 
each subject's initial agreement to participate in the study, the 
experimenter drew a token from the container marked with their gender in 
order to determine treatment assignment. In the case of group 
administration, the experimenter drew a token from the container marked 
with the gender of the majority of the group. (Subsequent to each testing 
session, contents of each container were adjusted to accurately reflect 
remaining subjects needed.) After the initial 80 subjects had been tested, 
groups were not balanced for gender. At that time, a determination was 
made as to the additional subjects needed, by gender and treatment 
category, to achieve balance. These additional subjects were then 
assigned to treatments as available. 
Staffing 
Initial testing sessions were facilitated by the primary investigator. 
One-week posttests were administered by the primary investigator in the 
majority of cases. The only exceptions were for subjects who participated 
at the Center for Addictions Recovery and the Mid-Eastern Council on 
Chemical Abuse. For subjects at those locations, posttests were 
46 
administered by staff counselors at the end of regularly scheduled 
counseling sessions. The staff counselors who administered the posttests 
did not have access to the information contained therein. Completed quiz 
sheets were immediately inserted into manila envelopes and put aside for 
pickup by the primary investigator. 
Stimulus Materials 
Each stimulus condition included 25 items of salient information about 
the study, for a total of 30 possible units of information (some items 
contained more than one unit of information). Each item began with a 
heading statement, phrased as a question in the first person. The text of 
the item itself was phrased as an answer to the heading question. 
Content of the consent stimuli was congruent with applicable federal, 
professional, and Iowa State University requirements. (For a detailed 
description of the rationale for item inclusion, please refer to Appendix H.) 
Description of Printed Consent Information 
Printed consent information was presented at two levels of 
redundancy; simple and enhanced. 
Simple printed information. 
The simple printed information condition utilized five pages of standard 
consent information (Appendix I) printed at 10 characters per inch with a 
Courier font. The information form was written at a seventh grade level of 
reading difficulty, as assessed by both the Fry Readability Scale (Fry, 
1968, Spadaro, Robinson, & Smith, 1980) and the Flesch Readability 
Formula (Flesch, 1948,1974), as outlined in Appendix J. Grundner (1978, 
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1980) has asserted that these formulas are particularly well suited for use 
in analysis of the readability of consent forms. 
Enhanced printed information. 
The enhanced printed information condition utilized seven pages of 
consent information, printed in the same size and font as the simple 
condition (Appendix K). Content differed only in the addition of an 
illustrative elaboration after each element of consent information. As with 
the simple condition, text was written at the seventh grade level of reading 
difficulty. 
Description of Video Consent Information 
Video consent information was presented at two levels of redundancy: 
simple and enhanced. 
Simple video information. 
The simple video information condition utilized a short videotaped 
presentation of a female spokesperson. The spokesperson was unaware 
of the nature or hypotheses of the study. A male off-camera voice read the 
topic headings as questions. The spokesperson responded with 
essentially a verbatim rendering of the topic content found in the print 
version of the information sheet for the "Simple" condition, changing only a 
few words, in order to reflect viewing, rather than reading, the material 
(see Appendix L). 
Enhanced video information. 
The enhanced video information condition utilized a similar videotaped 
presentation of the spokesperson, dressed identically. A male off-camera 
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voice read the topic headings as questions. The spokesperson responded 
with essentially a verbatim rendering of the topic content found in the print 
version of the information sheet for the "Enhanced" condition, changing 
only a few words, in order to reflect viewing, rather than reading, the 
material (see Appendix M). 
Videotaped presentations were in full color, recorded on VMS HQ 
format at standard speed, and presented using a full-sized television 
screen. Care was taken to assure that all participating subjects were able 
to clearly see and hear the taped presentation. 
Production of video stimuli. 
The scripts for each of the two video taped presentations were 
essentially verbatim reproductions of the corresponding printed versions. 
The only difference in content consisted of slight wording changes to 
reflect watching and listening to the stimulus, rather than reading it. An 
off-camera male voice read the section headings, each of which was in the 
form of a question (e. g., "What is the nature of this study?"), and the on-
camera presenter stated the explanatory response (e. g., "The nature of 
this study is research."), 
A total of 34 sample videotaped presentations were initially produced: 
17 for each condition. Videos were recorded in full color on standard 1/2" 
VMS format using a combination camera/videocassette recorder. The 
distribution of the initial video presentations was as follows: 
Male presenter #1 : 5 simple versions, 5 enhanced versions 
Male presenter #2: 3 simple versions, 3 enhanced versions 
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Female presenter #1 : 6 simple versions, 6 enhanced versions 
Female presenter #2: 3 simple versions, 3 enhanced versions 
The sample videotapes were then reviewed by a certified media 
specialist, a doctoral level psychologist, and the experimenter. Tapes 
were subjectively rated on clarity of presentation, accuracy of 
presentation, and freedom from distraction. By consensus, two tapes by 
female presenter #1 were chosen as the most acceptable presentations of 
the two consent information scripts. 
The length of the Simple Video presentation was 233 seconds. The 
Enhanced Video presentation lasted 364 seconds. 
Individualized Treatment 
Treatments were administered on either an individual basis or within a 
small group (2 - 5 persons). Even in the small group setting, however, 
administration of the stimulus and the testing was essentially individual. 
Subsequent to the provision of orientation information and an opportunity 
to agree to or decline participation (see below), subjects were randomly 
assigned to one of the four treatment conditions. 
Informed Consent Procedures 
Inasmuch as all experimental treatments were presentations of 
consent information, subjects in this study received full consent 
information along with an opportunity to agree to or decline participation, 
prior to administration of test protocols. Because informed consent is itself 
the treatment of study, however, the provision of full consent information 
prior to the administration of the experimental treatments would confound 
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the results of post-treatment testing. Yet, involvement of subjects in 
experimental treatment prior to being given the opportunity to make an 
informed choice regarding participation appears to violate clear ethical 
guidelines. 
Benjamin Freedman (1982) defined "ignorant consent" as "that offered 
under less information than that used by the reasonable person in arriving 
at a decision" (p. 4). He suggested that, in certain circumstances, such 
consent could be valid, although he failed to delineate the parameters of 
those circumstances. In order to address this problem in a manner which 
would satisfy ethical requirements yet have little or no impact upon test 
results, orientation information was read to all potential subjects at the 
beginning of each meeting. The orientation statement provided a basic 
description of the study and allowed potential subjects an opportunity to 
make an initial decision to participate or not, based upon minimally 
adequate information. 
Individuals were read the following orientation statement: 
"We are conducting a study on communication with people in 
treatment for alcohol abuse or dependency. If you decide to participate, 
you will be provided some information. Then you will be asked to answer 
some questions. A week from today, you'll be asked to answer a few 
more short questions. After you finish, you will be provided with detailed 
information about the study. I will need your written permission to include 
you in the study and I will not collect any materials from you until I receive 
your written permission. 
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"In order to participate in this study you must be 18 to 61 years old, 
inclusive, in treatment for alcohol abuse or dependency, and you must 
have been sober for at least the last 72 hours. Also, you must not be 
currently taking any medication, other than vitamin supplements, to aid in 
detoxification. 
"We appreciate you listening to this information. If you do not wish to 
participate, please say so now. If you would like to help, we will begin in a 
few minutes." 
Information presented during the initial orientation was not included in 
the data tested for during the assessment phase It is felt that the 
information provided at this stage was enough to allow a "reasonable 
person" to make a decision upon further participation, especially with the 
knowledge that their data would only be used after they had given their 
written permission. Subsequent to the presentation of orientation 
information and the provision of an opportunity to decline to participate, 
subjects were randomly assigned to treatment conditions. After 
presentation of the experimental treatment, subjects were again given the 
choice to participate or decline, and were requested to sign a consent 
sheet (Appendices N & O) before testing. 
The information presented to all subjects after completion of the 
delayed testing phase consisted of a printed description of the study 
(Appendix P) along with an open-ended question and answer session. 
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Measures 
Initial Assessment of Informed Consent Comprehension 
Taub, Baker, Kline, and Sturr (1987) suggest that subjects should 
retain access to the consent information during testing. Otherwise, they 
assert, assessment results will reflect recall, not comprehension. While it 
is recognized that short term recall can be a confounding element in this 
type of comprehension assessment, it is argued that the short recall 
interval involved in immediate post-exposure testing does not significantly 
interfere in the assessment of functional comprehension. By necessity, 
informed consent is a process which requires holistic comprehension. 
Agreement, or refusal, to participate is given after an adequate 
understanding of a body of salient information is obtained, not given 
serially upon understanding of each of the component parts. Sequential 
comprehension of individual components of information, in the absence of 
an ability to appreciate the whole, is inadequate for valid consent. 
Consequently, recall was considered to be an integral part of 
comprehension, for the purposes of this study. Subjects were 
administered the Questionnaire and Informed Consent Quiz (Appendix Q) 
immediately after exposure to the experimental condition (i.e., immediately 
after exposure to consent information). Because the intent of the Informed 
Consent Quiz was to assess comprehension, and not merely rote recall, a 
short answer format was used, rather than multiple choice. Each test item 
consisted of a topic heading from the Information Sheet. (All topic 
headings on the information sheet were written in the form of a question.) 
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There were 25 items, for a total of 30 possible points (some items were 
multi-point). 
Each subject was given a copy of the Informed Consent Quiz. The 
following instructions were read by the facilitator: 
"Please write your name and the requested information in the space 
provided on the first page only. When you're done with the questions on 
the first page, please stop and look up." 
After the subject completed the first page (which was the demographic 
questionnaire) the tester read the following statement, "This quiz will ask 
you several questions about this very study that we're doing today. Each 
question is followed by a space in which you may write the answer. Please 
answer each question. 
"You will have up to 15 minutes to answer these questions. I'll tell you 
when the time is up. Ready? Begin." 
After the subject completed the quiz, or after the 15 minute testing 
period had elapsed, the facilitator asked the subject to place the Informed 
Consent Quiz protocol aside, making sure that he or she had provided the 
identifying information requested at the beginning of the questionnaire. 
Protocols were assigned temporary subject numbers, and the 
demographic questionnaire sections of each protocol were detached from 
the body of the tests prior to scoring. Tests were scored utilizing the 
Informed Consent Quiz Answer Key (Appendix R). Responses which 
were substantially similar in content to the answer given in the Key were 
considered correct. 
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In order to calculate interscorer reliability, 30 test protocols, selected at 
random, were scored by both the primary investigator and an associate, 
utilizing the Answer Key. The associate was blind to the hypotheses of 
the study and was unaware of the results of the investigator's scoring of 
the sample protocols. Interscorer reliability was calculated to be .9836 
(E < .01, 2-tailed). As a result of the high degree of interrater reliability, the 
primary investigator, blind to experimental condition, acted as scorer for 
the comprehension instrument administered to all subjects. 
The tests were initially scored by the primary investigator and the 
initial, temporary scores were recorded. To enhance accuracy of scoring, 
the tests were rescored one week later. At that point, final scores were 
recorded for the protocols. 
Assessment of Vocabulary Function 
Immediately after completion of the Informed Consent Quiz, subjects 
were administered the Reading subtest of the Wide Range Achievement 
Test - Revised (WRAT-R, Jastak & Wilkinson, 1984), a task involving 
recognizing and naming letters and pronouncing words of increasing 
difficulty out of context. This WRAT-R yields a score which was converted 
to a grade level rating for the purpose of eligibility determination. The 
score was converted to a standard score for purposes of comparison and 
analysis. 
Delaved Assessment of Informed Consent Comprehension 
Seven days after the initial exposure to the experimental treatment, 
subjects met again with the facilitator or a staff person for retesting. They 
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were again administered the Informed Consent Quiz, with the facilitator 
following essentially identical procedures. Subsequent to completion of 
the retesting procedure, subjects were given a printed descriptive 
summary of the study along with the opportunity to ask the facilitator any 
questions about the study. Subjects were given the opportunity to request 
copies of the results upon completion of the study. 
Data Analysis 
Desion 
This study is a 2 X 2 complete factorial experiment (redundancy 
[single, enhanced] X format [printed, video]) with equal cell size. A 
randomized group design was used, with 20 participants for each 
treatment. Because of the randomized assignment of subjects to 
treatment conditions, a significant cohort effect was not expected. The 
dependent variables of interest in this study were the scores on the initial 
Comprehension Quiz and the Posttest. 
Since treatment levels of redundancy and format were not selected 
randomly, a fixed-effect analysis of variance (ANOVA) was used to test 
the significance of the effects of both treatment variables on initial 
comprehension. A similar ANOVA was planned to examine the effects of 
the treatment variables upon delayed performance. As will be noted, 
however, not enough posttests were completed to allow analysis for one-
week recall. Appropriate descriptive statistics regarding obtained 
demographic data are provided. 
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To provide further insight into the relationship among cognitive 
function, demographic variables, and comprehension, several 
relationships were examined, including those: between initial test scores 
and posttest scores, between score on the WRAT-R Reading subtest and 
performance on the comprehension test, between age and performance 
on the comprehension test, between gender and performance on the 
comprehension test, and between educational level and performance on 
the comprehension test. 
Data analysis was performed on an Apple Macintosh Classic II 
computer with an Applied Engineering 68882 floating-point math 
coprocessor installed. The software packages utilized were SPSS, 
Version 4.0 (SPSS. 1990a) and SPSS Advanced Statistics (SPSS, 
1990b). 
This research was approved by the Iowa State University Human 
Subjects Review Committee. 
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RESULTS 
Preliminary Analyses 
Power Analysis 
A power analysis of the ANOVA design, a 2 X 2 complete factorial 
experiment with 20 subjects in each cell, was undertaken, utilizing the 
master table found in Kraemer & Thiemann's (1987) informative work on 
statistical power analysis in research. The results indicated a power (5% 
level, 2-tailed) of 99% for a large effect size (.80 s.d.) and a power of 65% 
for a moderate effect size (.50 s.d.). 
Internal Consistency of the Test 
Cronbach's alpha, a measure based upon the internal consistency of 
the test items, was calculated at a = .74. 
Effect of Gender upon Comprehension Scores 
An analysis of variance was performed to ascertain the effect of gender 
upon initial comprehension scores (Table 3). No significant effect [F(1,78) 
= 1.60, B = .21] was noted. Analyses were, therefore, collapsed across 
gender. 
Inferential Analyses 
Immediate Comprehension 
Hypothesis Testing 
An analysis of variance was performed to determine the effects of the 
two independent variables of primary concern (redundancy and format) 
upon initial comprehension score (Table 4). Results of the analysis 
showed no significant effect from Redundancy [F(1,76) = .09, e ^ .77], 
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Table 3. Analysis of variance of comprehension score by gender 
Mean Std Dev Sum of Sa Cases 
Male 17.92 3.87 884.58 60 
Female 19.15 3.47 228.55 20 
Within Groups Total 18.23 3.78 1113.13 80 
Sum of Mean 
Source Souares dl Sauare F 
Between Groups 22.82 1 22.82 1.60 
Within Groups 1113.13 78 14.27 
Format [F(1, 76) = 1.11, b < .30], or an interaction of the two variables 
[F(1,76) = .88, B < .35]. Neither Hypothesis 1 (Enhanced redundancy of 
presented information will result in a higher level of comprehension of the 
material, as reflected in a higher score on the Comprehension Quiz, than 
unitary presentation of the information ) nor Hypothesis 2 (Video 
presentation of the stimulus information will result in a higher level of 
comprehension of the material, as reflected in a higher score on the 
Comprehension Quiz, than presentation via a printed format.) was 
supported by the results of the analysis. 
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Table 4. Analysis of Variance of comprehension score by redundancy by 
format 
Sum of Mean Sig 
Source Sauares DF Sauare F of F 
Main Effects 17.45 2 8.73 .60 .55 
REDUNDANCY 1.25 1 1.25 .09 .77 
FORMAT 16.20 1 16.20 1.11 .30 
2-Way Interactions 12.80 1 12.80 .88 .35 
REDUNDANCY X FORMAT 12.80 1 12.80 .88 .35 
Explained 30.25 3 10.08 .69 .56 
Residual 1105.70 76 14.55 
Total 1135.95 79 14.38 
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Comparison of Scores bv Site of Administration 
Subject data were collected at five different treatment centers in the 
state of Iowa (Appendix G). A one-way analysis of variance of the effect 
of site upon initial comprehension test score (Table 5) indicated inequality 
of population means (F(4, 75) = 3.39, e < .01). In order to identify the 
significant differences among population means, a Scheffé multiple 
comparison procedure was used. The Scheffé procedure is conservative 
for pairwise comparisons of means and requires larger differences 
between means for significance than most of the other methods (Gravetter 
& Walinau, 1988). The results of the Scheffé procedure suggest a 
significant difference between the population means of site 3 (CFARI) and 
site 5 (MECCA). Three subjects were tested at site 5, yielding the highest 
mean test result of the 5 sites. The mean test result for site 5 was 7.67 
points (2.52 s.d.) above the mean test result for site 3, the lowest mean. 
The mean score for site 5 was 5.92 points (1.79 s.d.) above the mean test 
result for site 2, the second highest mean score. 
In order to examine the potential effect upon the overall analysis of the 
data by the three site 5 scores, a revised data set of 77 subjects was 
created which did not include the site 5 scores. An analysis of variance 
was performed to determine the effects of the two independent variables 
of primary concern (redundancy and format) upon initial comprehension 
score (Table 6). Results of this analysis were equivalent to the results of 
the ANOVA performed upon the entire 80 subject data set. The decision 
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Table 5. Analysis of variance of comprehension score by site of 
administration 
ANALYSIS OF VARIANCE 
SOURCE 
SUM OF 
D.F. SQUARES 
MEAN 
SQUARES 
F 
RATIO 
F 
PROB. 
BETWEEN GROUPS 4 173.93 43.48 3.39 .01 
WITHIN GROUPS 75 962.02 12.83 
TOTAL 79 1135.95 
FREQUENCY OF TREATMENT TYPE BY SITE OF ADMINISTRATION 
1 1 S 1 S 1 1 E 1 1 E 1 1 1 
1 
1 
P 1 
1 
V 1 
1 
P 1 
1 
V 1 T 
1 R 1 1 1 R 1 1 1 0 
1 1 1 D 1 1 1 D 1 T 
Mean 1 N 1 E 1 N 1 E 1 A 
1 
1 
T 1 1 0 1 T 1 1 0 1 1 L 
17.00a SITE 3 1 
1 
1 
8 1 1 
... 1 
15 1 1 
1 
1 1 1 
1 
5 1 1 29 
18.33 SITE 4 1 
1 
0 1 1 
1 
0 1 1 
1 
0 1 1 
1 
3 1 1 3 
18.54 SITE1 1 
1 
1 
9 1 1 
1 
5 1 1 
1 
11 1 1 
1 
12 1 1 37 
18.75 SITE 2 1 1 1 1 
1 
1 
0 1 
1 
1 
7 1 
1 
1 
0 1 
1 
8 
24.673 SITES 1 
1 
1 
2 1 1 
1 
0 1 
1 
1 
1 1 1 
1 
0 1 
1 
3 
TOTAL 
- 1 
20 1 20 1 20 20 1 80 
aScheffé multiple comparison procedure indicates sites 3 and 5 
significantly different at the .05 level. 
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Table 6. Analysis of Variance of comprehension score by 
redundancy by format, eliminating data from site #5 
Sum of Mean Sig 
Source Souares DF Square F of F 
Main Effects 3.36 2 1.68 .125 .88 
REDUNDANCY .06 1 .06 .01 .95 
FORMAT 3.31 1 3.31 .25 .62 
2-Way Interactions 20.53 1 20.53 1.53 .22 
REDUNDANCY X FORMAT 20.53 1 20.53 1.53 .22 
Explained 23.89 3 7.96 .59 .62 
Residual 980.06 73 13.43 
Total 1003.95 76 13.21 
was therefore made to include data from the three site 5 subjects in the 
study. 
Confidence in the Null Hypothesis 
Power analysis of the ANOVA design (Kraemer & Thiemann, 1987) 
indicates a power of 99% for a large effect size (.80 s.d.) and a power of 
65% for a moderate effect size (.50 s.d.). A cautious interpretation of the 
data suggests acceptance of the equivalency of the four tested treatments, 
for large effects on immediate comprehension, as measured by the 
Comprehension Quiz. 
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One-Week Recall 
Data Collection Difficulties 
Assessment of recall of consent Information at the one-week follow-up 
point was hampered severely by programmatic factors. Several subjects 
failed to attend scheduled posttest sessions due to: 
a) dropping out of treatment, 
b) loss of insurance coverage, resulting in discontinuation of 
treatment, 
c) early completion of treatment, 
d) failure of hospital staff to notify the patient of their appointment, 
e) voluntarily quitting the study. 
Of the 80 subjects involved in the study, only 28 completed posttests. 
As a result of the paucity of posttest data, the data were not analyzed to 
test Hypothesis 3 (Enhanced redundancy of presented information will 
result in a higher level of recall of the material, as reflected in a higher 
score on the Comprehension Posttest, than unitary presentation of the 
information ) or Hypothesis 4 (Video presentation of the stimulus 
information will result in a higher level of recall of the material, as reflected 
in a higher score on the Comprehension Posttest, than presentation via a 
printed format.). 
Relationship of Immediate Comprehension Scores to Posttest Scores 
As noted previously, difficulties were experienced in obtaining full 
participation in the follow-up portion of the study. Only 35% of the 
posttests were completed. Although initially planned to occur at exactly 
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one week after the initial testing, the amount of time from initial testing to 
posttest ranged from 7 to 14 days. Results involving posttests should, 
therefore, be interpreted with care and regarded as general descriptives. 
Attrition of the posttest sample due to extraneous factors could skew 
the data. To test the independence of "dropping out", an analysis was 
performed, comparing the initial comprehension scores of the 28 subjects 
who successfully completed the posttest to the initial comprehension 
scores of 28 randomly selected subjects who failed to complete the 
posttest. The results (U27] = .04, g = .97) indicated no significant 
differences between the samples, suggesting that failure to complete the 
posttest was randomly distributed. 
The relationship between initial Comprehension Quiz scores and 
posttest scores was examined, collapsing across cells. Examination of a 
scatterplot of the two scores (Figure 2) revealed a positive association 
between initial comprehension score (SCORE 1) and posttest score 
(SC0RE2). 
Pearson correlation coefficients were calculated to quantify the 
strength of the association (Table 7). A significant correlation (r = .65, 
B = .00) was noted between initial Comprehension Quiz scores and 
posttest scores. 
Results also suggest that if subjects remember consent information 
immediately subsequent to its presentation, they are likely to remember it 
after approximately one week. A 2-tailed , paired-sample t-test 
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Figure 2. Scatterplot: Comprehension scores with posttest scores 
(SC0RE1 = immediate comprehension test 
SC0RE2 = one week follow-up test) 
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Table 7. Correlation between initial comprehension score (SC0RE1) 
and posttest score (SC0RE2) 
SCORE1 SC0RE2 
SC0RE1 1.00 .65** 
SC0RE2 .65** 1.00 
* Significant at e ^ 05 (2-tailed). 
** Significant atg < .01 (2-tailed). 
(t (27) = .34, e =.73) indicated no significant differences between initial test 
scores and posttests (Table 8). 
Two potential confounds are noted, however, which may affect the 
validity of these observations regarding initial test/posttest correlation. 
The nature of chemical dependency treatment is such that most subjects 
spent many hours each day in close proximity to other patients in the 
treatment program, some of whom were subjects. Although subjects were 
requested at the end of both testing sessions to not share information 
about the study with other current or potential subjects, some information 
sharing may have occurred. 
A second, and potentially more serious confound, results from the 
experimental design. The information about which subjects were tested in 
the Comprehension Quiz was specific, descriptive information about the 
study. At the time of posttesting, subjects had already participated in one 
Table 7. T-test, SC0RE1 versus SCORE2 
Number Standard 
Variable of Cases Mean Deviation 
SC0RE1 28 18.46 3.04 
SC0RE2 28 18.29 3.48 
(Difference) 
(Difference) Standard 
Mean Deviation 
.18 2.75 
Standard 
Error 
.57 
.66 
(Difference) 
Standard 2-tail t Degrees of 2-tail 
Error Corr. Prob. Value Freedom Prob. 
.52 .65 .000 .34 27 .73 
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testing session, and had an opportunity to consider their experience over 
the one-week interim. The experience of participation itself may have 
provided subjects with pertinent information regarding the study. Such 
information as the voluntariness of participation, activities required of 
subjects, and confidentiality of data may have been conveyed by the 
participation experience. This learning dynamic may have served to offset 
potential forgetting of information tested for in the posttest. 
Effect of Reading Variables 
Effect of WRAT-R Reading Subtest Performance 
on Comprehension Score 
Subjects were administered the Reading subtest of the WRAT-R as a 
screening instrument. Language proficiency may be seen as an essential 
component of comprehension of consent information. To investigate this, 
a scatterplot was constructed, plotting comprehension scores against 
WRAT-R standard scores. (Figure 3). A small positive association 
between the two variables seemed apparent. In order to quantify the 
strength of the association, Pearson correlation coefficients were 
calculated (Table 9). These calculations confirmed a small, but significant 
association between comprehension score and WRAT-R standard score 
(r = .23, p < .05). 
WRAT-R standard scores reflect subject performance relative to his or 
her age norm group. Comprehension scores, however, reflected raw, not 
age standardized, scores. The salient measurement was how much of the 
consent information the subject comprehended, not how well they did 
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Table 9 Correlation between comprehension score and WRAT-R 
Reading subtest standard score 
SCORE WRAT SS 
SCORE 1.00 .23* 
WRAT SS .23* 1.00 
* Significant at e < .05 (2-tailed) 
** Significant at e < .01 (2-tailed) 
relative to their peers. Level of vocabulary function, in an absolute sense, 
may significantly affect comprehension of consent information, regardless 
of its relationship to the vocabulary performance of the norming 
population. Therefore, a second scatterplot was constructed, plotting 
comprehension scores against WRAT-R raw scores (Figure 4). A small 
positive association, quite similar to that between comprehension scores 
and WRAT-R standard scores, was apparent. A Pearson correlation 
coefficient was calculated (Table 10), confirming a small, but significant, 
positive association (r = .25, e ^ 05). 
Since the printed conditions of consent Information relied heavily upon 
reading ability, the possibility of an interaction between format and WRAT-
R performance was investigated (Tables 11 and 12). Regression analysis 
failed to support a significant interaction between WRAT-R standard 
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Table 10. Correlation between comprehension score and WRAT-R 
Reading subtest raw score 
SCORE WRAT 
SCORE 1.00 .25* 
WRAT .25* 1.00 
* Significant at ^ < .05 (2-tailed) 
** Significant atp < .01 (2-tailed) 
Table 11. Multiple regression table, WRAT-R standard score, format, 
and their interaction 
Variable B SE^ & Î 
WRAT-R SS .15 .13 
FORMAT 4.07 7.47 
INTERACTION -.05 .08 
(Constant) 4.97 12.21 
.43 
.54 
.60 
1.17 
.55 
-.62 
.41 
.25 
.59 
.54 
.68 
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Table 12. Multiple regression table, WRAT-R raw score, format, and 
their interaction 
Variable B SEB & Î Significance of t 
WRAT-R .17 .14 
FORMAT 2.84 5.53 
INTERACTION -.05 .09 
(Constant) 8.31 8.81 
.44 
.38 
.45 
1.25 
.51 
-.62 
.94 
.22 
.61 
.54 
.35 
scores and format (t = -.62, b= .54). Similarly, for WRAT-R raw scores, 
no significant interaction with format was supported (t = -.62, e= .54). 
Relationship of Time-to-Read-Stimulus to Comprehension Scores in 
Printed Conditions 
Subjects were given up to fifteen minutes to read consent information 
in the printed conditions. The range of actual times-to-read was from 84 
seconds.to 375 seconds. Careful reading of material may take longer than 
cursory examination, but may also result in higher comprehension. To 
examine the relationship between time-to-read and comprehension score, 
a scatterplot of scores with their corresponding times-to-read was 
constructed (Figure 5). No discernible relationship between the two 
variables was apparent. Pearson correlation coefficients were calculated, 
confirming the lack of apparent relationship (Table13). 
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Table 13. Correlation between comprehension score and reading time 
SCORE TIME TO READ 
SCORE 1.00 -.14 
TIME TO READ -.14 1.00 
* Significant at e < .05 (2-tailed) 
** Significant at e < .01 (2-tailed) 
Effect of Education upon Comprehension Scores 
Holding G. E. D. Equivalent to HS Degree 
Subjects in this study reported completion of from 9 to 16 years of 
formal education. Seventeen subjects had completed certificates of 
general educational development (G. E. D.), customarily accepted as 
equivalent of high school completion. Pearson correlation coefficients 
were calculated to ascertain the relationship of educational attainment to 
initial comprehension scores. G. E. D. completion was held equal to 
completion of 12 years of education for purposes of this analysis (Table 
14.). The results showed no apparent significant relationship between 
educational level (with G. E. D. = 12 years) and comprehension scores 
(£=.11) 
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Table 14. Correlation between comprehension score and years of 
education, with attainment of a GED = 12 years 
SCORE YEARS OF EDUCATION 
SCORE 1.00 .11 
YEARS OF EDUCATION .11 1.00 
* Significant at e < .05 (2-tailed) 
** Significant at g < .01 (2-tailed) 
Actual Years of Educational Attainment 
Completion of a G. E. D. may not indicate true high school 
equivalency, however. In order to more completely investigate the 
potential effect of education, another correlation was performed to 
ascertain the relationship of educational attainment to initial 
comprehension scores. In this second correlation, the education variable 
reflected the actual number of years of formal education completed, 
notwithstanding possible completion of a G. E. D. (Table 15). Results of 
this analysis also indicated no overall significant relationship of 
educational attainment to initial comprehension scores (r = .13). 
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Table 15. Correlation between comprehension score and actual years 
of education 
SCORE YEARS OF EDUCATION 
SCORE 1.00 .13 
YEARS OF EDUCATION .13 1.00 
* Significant at e < .05 (2-tailed) 
** Significant at e < .01 (2-tailed) 
Interaction of Format and Education 
A major difference between the two formats of information presentation 
used in this study was the requirement for the printed format that the 
subject be able to read the document for understanding whereas an ability 
to read was not necessary for the stimulus presentation phase of the video 
format. Level of educational attainment may reflect ability to read, 
understand, and retain printed material. Thus, an interaction of 
educational attainment and format could be expected, with years of 
educational attainment positively related to printed format scores, but not 
necessarily video format scores. Appropriate ANOVAs were performed to 
analyze for possible interaction between education and format. No 
significant main effect from educational level (F(7,66) = 1.38, e = .23) or 
significant interaction between format and educational level 
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(F(5,66) = 1.49, 6= .21) was found when the education variable reflected 
actual years of formal education completed (Table 16). 
When attainment of a G. E. D. was held equivalent to 12 years of 
formal education, a borderline interactive effect was noted 
(F(3, 68) = 2.41, B= .08, Table 17). Although it is tempting to speculate 
on the implications of the suggested interactive effect, such speculations 
must be tempered by the borderline significance of the findings. 
Table 16. Analysis of Variance of comprehension score by format and 
actual years of formal education 
Sum of Mean Sig 
Source Souares DF Sauare F of F 
Main Effects 146.66 8 18.33 1.36 .23 
FORMAT 22.04 1 22.04 1.64 .21 
ED 130.46 7 18.64 1.38 .23 
2-Way Interactions 100.42 5 20.08 1.49 .21 
FORMAT X ED 100.42 5 20.08 1.49 .21 
Explained 247.07 13 19.01 1.41 .18 
Residual 888.88 66 13.47 
Total 1135.95 79 14.38 
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Tablel 7. Analysis of Variance of SCORE 1 by format and years of 
education, with attainment of a GED held equal to 12 years 
Source 
Main Effects 
FORMAT 
ED 
2-Way Interactions 
FORMAT X ED 
Explained 
Residual 
Total 
Sum of 
Souares DF 
74.74 8 
21.88 1 
58.54 7 
101.92 3 
101.92 3 
176.67 11 
959.28 68 
1135.95 79 
Mean Sig 
Sauare F of F 
9.34 .66 .72 
21.88 1.55 .22 
8.36 .59 .76 
33.97 2.41 .08 
33.97 2.41 .08 
16.06 1.14 .35 
14.11 
14.38 
Effect of Age upon Comprehension Scores 
Subjects in this study ranged from 18 to 53 years of age. To 
investigate the possible relationship between subject age and 
comprehension score, a scatterplot was constructed, plotting 
comprehension scores against subject age (Figure 6). No discernible 
relationship between the variables was apparent. Pearson correlation 
coefficients were calculated, confirming the lack of apparent relationship 
(Table 18). 
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Figure 6. Scatterplot: Comprehension scores with subject age 
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Table 18. Correlation between comprehension score and age 
SC0RE1 AGE 
SC0RE1 1.00 -.19 
AGE -.19 1.00 
* Significant at b < .05 (2-tailed) 
** Significant at g < .01 (2-tailed) 
Item Analysis 
The quiz was constructed of 25 questions, paralleling the structure of 
the stimulus information, containing a total of 30 scorable points (some 
items contained more than one element of information). Each question 
was followed by 5 blank lines, allowing the subject adequate room to 
answer the question as fully or as briefly as desired. Quizzes were scored 
utilizing the Scoring Criteria and procedures enumerated in Appendix R. 
Table 19 details descriptive statistics for each item. 
Questions 16 through 20 were answered correctly by all subjects, mall 
conditions. The questions, with the correct answers in parenthesis, are 
listed below. 
Question 16: "Do you have to take part in the study?" (No) 
Question 17: "Will you be penalized if you refuse to take part in the 
study?" (No) 
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Table 19. Descriptive statistics for quiz items 
Question Mçan Std Dev 
Q1 .31 .47 
Q2 .29 .46 
Q3A .71 .46 
Q3B .44 .50 
Q4A .19 .39 
Q4B .25 .44 
Q4C .05 .22 
Q5A .39 .49 
Q5B .09 .28 
Q6 .48 .50 
07 .22 .42 
08 .90 .30 
09 .76 .43 
010 .94 .24 
011 .99 .11 
012 .87 .33 
013 .83 .38 
014 .79 .41 
015A .26 .44 
0158 .45 .50 
016 1.00 .00 
017 1.00 .00 
018 1.00 .00 
019 1.00 .00 
020 1.00 .00 
021 .96 .19 
022 .45 .50 
023 .19 .39 
024 .76 .43 
025 .67 .47 
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Question 18: "Will you lose any benefits if you refuse to take part in 
the study?" (No) 
Question 19: "Will you be penalized if you quit the study after 
you've started?" (No) 
Question 20; "Will you lose any benefits if you quit the study after 
you've started?" (No) 
Questions 16-20 all deal with the subject of voluntariness, and as such 
may essentially be asking different aspects of the same question. Since 
the items have zero variance, statistical interpretation is limited, however. 
Additionally, only two subjects missed Question 21, which also pertained 
to voluntariness and the subject's right to quit at any time ("If you quit the 
study, what kind of reason must you give?" [None]). Because of their 
similarity, presentation of the stimulus information for these items may 
have constituted an extreme example of information redundancy. 
Additionally, voluntariness as an essential component of research 
participation may be common knowledge among members of the sampled 
population. The lack of a no-treatment control group in this study 
precludes support for that conclusion, however. 
Items 8,10, and 11 all were answered correctly over 90% of the time. 
The questions are listed below. (Since answer criteria for these items are 
more complex than for items 16-21, the reader is referred to Appendix R 
for details of scoring.) 
Question 8: "To what extent, if any, is your participation 
confidential?" 
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Question 10: "To what extent is what you tell us confidential?" 
Question 11 ; "Will the questionnaire and quizzes have your name 
on them?" 
These items focus on confidentiality of participation and the resulting 
identifying data and may be seen to reflect the effect of multiple 
presentations of similar informative statements about confidentiality. Also, 
they may possibly tap into another common belief about research 
participation. 
Questions 4C and 5B were answered correctly less than 10% of the 
time. Each reflects part of a multi-element item. Their text is listed below. 
Question 4. "What will you have to do?" (Part C refers to the activity 
of taking another quiz one week after the initial meeting.) 
Question 5. "What will the quizzes be about?" (Part B refers to the 
vocabulary assessment.) 
These question sub-parts appeared to assess memory for information 
elements which were idiosyncratic for the study and had little relevance to 
concepts of participant rights. Additionally, as sub-parts of information 
items, they may have "competed for hierarchical space" in subject memory 
paradigms for the overall items. Thus, the posttest may have been 
recalled more poorly because of its perceived temporal distance and lower 
relevance to the task at hand. The vocabulary assessment may have 
been recalled more poorly because of an apparent lack of relevance to the 
overall gestalt of the study. 
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All items except 4C, 11, and 16-21 (see above) correlated positively 
and significantly with overall test score (Table 20). When a Pearson 
correlation coefficient was calculated between individual items and the 
sum of the scores on all the other items, however (Table 21, "Corrected 
item-total correlation"), the relationship of individual items to the others 
was seen to range from a low of zero for the 5 items with zero variance 
(16-20) to a high of .54 for Item 1 ("What is the nature of this study? 
[Research]). 
Cronbach's alpha, a measure based upon the internal consistency of 
the items, was calculated at a = .74. 
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Table 20. Correlation of individual quiz items with total comprehension 
score 
Item Total score 
01 .62** 
02 .59** 
03A .38** 
03B .40** 
04A .35** 
Q4B .38** 
04C .20 
Q5A .57** 
05B .23* 
06 .30** 
07 .49** 
08 .30** 
09 .35** 
010 .29** 
011 .16 
012 .45** 
013 .54** 
014 .57** 
015A .29** 
0158 .29* 
016 
017 
018 
019 
020 
021 .15 
022 .36** 
023 .25* 
024 .35** 
025 .33** 
". " is printed if a coefficient cannot be computed 
* Significant at e < .05 (2-tailed) 
** Significant at g < .01 (2-tailed) 
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Table 21. Item-total statistics 
SCALE SCALE 
MEAN VARIANCE 
IF ITEM IF ITEM 
DELETED DELETED 
CORRECTED 
ITEM 
TOTAL 
CORRELATION 
ALPHA 
IF ITEM 
DELETED 
01 17.93 12.32 .54 .71 
02 17.95 12.48 .50 .71 
Q3A 17.53 13.24 .26 .73 
Q3B 17.80 13.07 .27 .73 
Q4A 18.05 13.44 .25 .73 
Q4B 17.99 13.25 .27 .73 
Q4C 18.19 14.03 .14 .74 
Q5A 17.85 12.43 .47 .72 
Q5B 18.15 13.90 .15 .74 
06 17.76 13.40 .18 .74 
07 18.01 12.90 .41 .72 
08 17.34 13.75 .21 .73 
09 17.48 13.37 .24 .73 
010 17.30 13.86 .22 .73 
Oil 17.25 14.19 .13 .74 
012 17.36 13.27 .38 .73 
013 17.41 12.88 .47 .72 
014 17.45 12.68 .50 .72 
015A 17.98 13.52 .18 .74 
0158 17.79 13.49 .16 .74 
016 17.24 14.31 .00 .74 
017 17.24 14.31 .00 .74 
018 17.24 14.31 .00 .74 
019 17.24 14.31 .00 .74 
020 17.24 14.31 .00 .74 
021 17.28 14.13 .10 .74 
022 17.79 13.18 .24 .73 
023 18.05 13.74 .14 .74 
024 17.48 13.37 .24 .73 
025 17.56 13.34 .22 .74 
Alpha = 0.74 
88 
DISCUSSION 
This study investigated the effect of information repetition and media 
format upon comprehension and recall of consent information in a sample 
of chronic alcoholics. Relationships between several other variables and 
information comprehension were also examined. 
The findings did not support the effectiveness of redundant information 
presentation to increase comprehension of consent material in the 
sampled population. Neither did they support the effectiveness of video 
format over print format in the presentation of consent information. No 
significant interactive effects were noted. 
Equivalency of Print and Video Formats 
The lack of significant difference in the four conditions is itself, 
however, a finding of value. As noted earlier, a power analysis of the 
ANOVA design, calculated at the 5% level (2-tailed), indicated that the 
probability of a correct acceptance of the null hypothesis, for a large effect 
size (.80 s^., or 2.43 points on the initial consent quiz), was 99%. Thus, 
relative equivalency of the treatments is suggested. 
Provision of informed consent in chemical dependency treatment is 
difficult in most instances. Patients are sometimes acutely intoxicated. If 
sober, they may be experiencing the cognitive clouding that often occurs 
during the acute post-detoxification period. Many patients are placed into 
treatment involuntarily, or "semi-voluntarily", and exhibit a high level of 
uncooperativeness. Even for cooperative, cognitively intact, patients, the 
first few days of treatment are complicated, confusing, and disorienting. 
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Provision of treatment information, including that required for the patient to 
provide truly informed consent to remain in treatment, is traditionally 
through printed handbooks or sign-off sheets. As noted by Mills (1990), 
patients often read these sheets only cursorily, if at all. The finding that 
video format presentation of consent information is at least as effective as 
traditional print methods gives treatment programs more flexibility in 
presentation of this important information. Additionally, utilization of a 
video format would allow programs to present consent information to large 
groups of patients at the same time. 
Initial presentation of important treatment information via video format, 
followed up by presentation of printed material with a sign-off sheet for 
documentation purposes, would be one possible innovative 
implementation of these findings. In this paradigm, exposure to the 
information could be assured, through monitored presentation of video 
information. Although patients would always have the option of not paying 
attention to the proffered video information, to do so would require an 
active decision on their part to ignore the material Conversely, in order to 
be exposed to printed information, patients must make an active decision 
to read the material. Thus, in the video paradigm, patient inaction would 
result in exposure to the information, while in the print paradigm, patient 
inaction would result in nonexposure to the information. Considering the 
volitional inertia exhibited by many patients during the initial weeks of 
chemical dependency treatment, video presentation of information could 
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facilitate communication of important treatment information in the clinical 
setting. 
Analogous to the presentation of clinical information, presentation of 
research consent information to alcoholics in treatment, or in acute post-
detoxification status, can be quite difficult. Research information may hold 
little interest for the subject who finds himself or herself in treatment for a 
chronic, life threatening illness, especially when complicated by cognitive 
clouding and emotional upheaval. Video presentation of consent 
information as an acceptable option in research with alcoholics would 
provide needed flexibility and many of the same benefits of facilitation of 
communication noted in the discussion of presentation of clinical 
information. 
Recall of Consent Information 
Significant correlative findings between initial test results and posttests 
support an interpretation that initial level of consent information 
comprehension is positively related to level of long-term recall of the 
material. Further, t-test results suggest that, once learned, recall tends to 
remain stable, at least during the first week. Considering that most 
chemical dependency treatment lasts only about one month, adequate 
recall of consent material during that time empowers the patient as an 
active partner in health care decision making. In light of the findings, 
clinicians would be urged to emphasize facilitation of comprehension of 
important, consent-related material during the initial phases of treatment. 
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Reading Ability and Comprehension of Consent Information 
Results suggest a small, but significant, correlation between 
vocabulary level and comprehension of consent material (r = .25, g < .05). 
Although statistical significance was observed, it is noted that this 
correlation only accounted for approximately 6% of the score variance, not 
a finding of clinical significance. Since the stimulus material was 
constructed at the 7th grade level of reading difficulty, effects of 
vocabulary ability may have been suppressed. The practical significance 
of these findings may decrease as treatment facilities rewrite consent 
information, emphasizing enhancement of readability and reduction of an 
historically high difficulty level. At this time, however, results suggest that 
patients with low vocabulary function or poor reading ability be provided 
with ancillary assistance in comprehension of important consent-related 
material. 
ANOVA results did not support a differential effect for vocabulary 
function for print versus video format. Even if programs utilize video 
presentation of consent information, it would be prudent to provide 
assistance to poor readers in order to enhance comprehension of the 
material. 
Educational Level and Comprehension of Consent Information 
No significant effects of educational level on consent information 
comprehension were noted. This finding seems to support the practice of 
simplification and clarification of presented material. Although no 
comparison data is available, it is tempting to speculate that educational 
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level may have been a significant factor in comprehension had the 
material been written at the post-graduate level, an all-to-common 
occurrence. 
Age and Gender 
No effects of either age or gender on comprehension were noted. It is 
stressed, however, that the sample consisted of patients between the 
ages of 18 and 53, inclusive. Thus, the potential confounds of youth, and 
senior status were avoided. It would be unwise to extrapolate these 
findings to include youthful or elderly populations, considering the special 
needs and problems which appear in each. 
Limitations of the Study 
While providing an adequate assessment of the effects of the target 
variables, several limitations were noted in both research design and 
implementation. 
The lack of a no-treatment control group left open the question of 
preexisting knowledge about consent information. The core of consent 
material consists of elements of confidentiality and voluntariness. As was 
noted in the previous section, these were precisely the areas in which 
subjects scored the highest. In the absence of a control group, the 
etiology of this scoring differential remains unknown. 
Difficulty with follow-up data prevented the testing of the two 
hypotheses regarding posttest performance. The dynamics of chemical 
dependency treatment (and the behaviors of chemically dependent 
patients) are significantly different than those found in the usual research 
93 
setting. More care sliould liave been taken to insure the collectability of 
posttests. 
The video stimuli used in this study were selected on the basis of their 
"neutrality." Several subjects referred to them as "boring." Video is an 
immensly flexible and creative medium. In fact, subjects may be more 
critical of the interest level of video presentations than of print 
presentations because they have come to expect video presentations to 
be both interesting and informative. Utilization of more sophisticated 
production facilities, and incorporation of a "level of interest" variable 
would have been quite useful. 
Conclusions 
Although results did not support the hypotheses of increased 
comprehension of consent material through the utilization of increased 
information redundancy and substitution of a video format instead of the 
usual printed one, findings were useful, both clinically and in the research 
setting. As discussed in the preceding section, potential equivalency of 
video and print formats in the efficiency of presentation of consent 
information to alcoholics provides clinicians and researchers with more 
flexibility by adding an option which easily allows for group and monitored 
presentation of information. The negligible effects on performance of 
educational level, vocabulary level, gender, and age (within the stated 
limits) lend support to the hope that patients and subjects throughout a 
wide range of demographic characteristics and cognitive ability can be 
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effectively provided with salient information about their treatment or the 
research in which they participate. 
Future research in this area is certainly Indicated, especially in the 
incorporation of interest and production variables into video consent 
presentation. As interactive video programs become more sophisticated 
and plentiful, through the use of personal computers with attached video 
disc systems, another potentially fruitful avenue of consent research 
opens. 
The question is no longer whether or not to provide meaningful consent 
information to subjects and patients, but rather in what manner the most 
effective and efficient presentation of that information can be made. 
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THE HIPPOCRATIC OATH 
PI I swear by Apollo Physician and Asclepius and Hygieia and Panaceia 
and all the gods and goddesses, making them my witnesses, that I will 
fulfill according to my ability and judgment this oath and this covenant: 
P2 To hold him who has taught me this art as equal to my parents and to 
live my life in partnership with him, and if he is need of money to give him 
a share of mine, and to regard his offspring as equal to my brothers in 
male lineage and to teach them this art- if they desire to learn it- without 
fee and covenant; to give a share of precepts and oral instruction and all 
the other learning to my sons and to the sons of him who has instructed 
me and to pupils who have signed the covenant and have taken an oath 
according to the medical law, but to no one else. 
P3 I will apply dietetic measures for the benefit of the sick according to 
my ability and judgment; I will keep them from harm and injustice. 
P4 I will neither give a deadly drug to anybody if asked for it, nor will I 
make a suggestion to this effect. Similarly I will not give to a woman an 
abortive remedy. In purity and holiness I will guard my life and my art. 
P5 I will not use the knife, not even on sufferers from stone, but will 
withdraw in favor of such men as are engaged in this work. 
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P6 Whatever houses I may visit, I will come for the benefit of the sick, 
remaining free of all intentional injustice, of all mischief and in particular of 
sexual relations with both female and male persons, be they free or 
slaves. 
P7 What I may see or hear in the course of the treatment or even outside 
of the treatment in regard to the life of men, which on no account one must 
spread abroad, I will keep to myself holding such things shameful to be 
spoken about. 
P8 If I fulfill this oath and do not violate it, may it be granted to me to 
enjoy life and art, being honored with fame among all men for all time to 
come: if I transgress it and swear falsely, may the opposite of all this be 
my lot. 
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DECLARATION OF GENEVA 
WORLD MEDICAL ASSOCIATION 
AMENDED, 1983 
At the time of being admitted as a member of the medical profession: 
I solemnly pledge myself to consecrate my life to the service of humanity; 
I will give to my teachers the respect and gratitude which is their due; 
I will practice my profession with conscience and dignity; 
The health of my patient will be my first consideration; 
I will respect the secrets which are confided in me, even after the patient 
has died; 
I will maintain by all the means in my power, the honor and the noble 
traditions of the medical profession; 
My colleagues will be my brothers; 
I will not permit considerations of religion, nationality, race, party politics or 
social standing to intervene between my duty and my patient; 
I will maintain the utmost respect for human life from its beginning even 
under threat and I will not use my medical knowledge contrary to the laws 
of humanity; 
I make these promises solemnly, freely, and upon my honor. 
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PRINCIPLES OF MEDICAL ETHICS 
AMERICAN MEDICAL ASSOCIATION 
REVISED, 1980 
The medical profession has long subscribed to a body of ethical 
statements developed primarily for the benefit of the patient. As a 
member of this profession, a physician must recognize responsibility not 
only to patients, but also to society, to other health professionals, and to 
self. The following Principles adopted by the American Medical 
Association are not laws, but standards of conduct which define the 
essentials of honorable behavior for the physician. 
I. A physician shall be dedicated to providing competent medical 
service with compassion and respect for human dignity. 
II. A physician shall deal honestly with patients and colleagues, and 
strive to expose those physicians deficient in character 
or competence, or who engage in fraud or deception. 
III. A physician shall respect the law and also recognize a responsibility 
to seek changes in those requirements which are contrary to the best 
interests of the patient. 
IV. A physician shall respect the rights of patients, of colleagues, and 
of other health professionals, and shall safeguard patient confidences 
within the constraints of the law. 
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V. A physician sliall continue to study, apply, and advance scientific 
knowledge, make relevant information available to patients, colleagues, 
and the public, obtain consultation, and use the talents of other health 
professionals when indicated. 
VI. A physician shall, in the provision of appropriate patient care, 
except in emergencies, be free to choose whom to serve, with whom to 
associate, and the 
environment in which to provide medical services. 
VII. A physician shall recognize a responsibility to participate in 
activities contributing to an improved community. 
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APPENDIX D: PATIENTS BILL OF RIGHTS 
(from Carrick, 1985, pp. 189-191) 
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A PATIENT'S BILL OF RIGHTS 
AMERICAN HOSPITAL ASSOCIATION 
1973 
The American Hospital Association presents a Bill of Rights with the 
expectation that observance of these rights will contribute to more 
effective patient care and greater satisfaction for the patient, his physician, 
and the hospital organization. Further, the Association presents these 
rights in the expectation that they will be supported by the hospital on 
behalf of its patients, as an integral part of the healing process. It is 
recognized that a personal relationship between the physician and the 
patient is essential for the provision of proper medical care. The traditional 
physician-patient relationship takes on a new dimension when care is 
rendered within an organizational structure. Legal precedent has 
established that the institution itself also has a responsibility to 
the patient. It is in recognition of these factors that these rights are 
affirmed. 
1. The patient has the right to considerate and respectful care. 
2. The patient has the right to obtain from his physician complete current 
information concerning his diagnosis, treatment, and prognosis in terms 
the patient can be reasonably expected to understand. When it is not 
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medically advisable to give such information to the patient, the information 
should be made available to an appropriate person in his behalf. He has 
the right to know by name the physician responsible for coordinating his 
care. 
3. The patient has the right to receive from his physician information 
necessary to give informed consent prior to the start of any procedure 
and/or treatment. Except in emergencies, such information for informed 
consent should include, but not necessarily be limited to the specific 
procedure and/or treatment, the medically significant risks involved, and 
the probable duration of incapacitation. Where medically significant 
alternatives for care or treatment exist, or when the patient requests 
information concerning medical alternatives, the patient has the right to 
such information. The patient also has the right to know the name of the 
person responsible for the procedures and/or treatment. 
4. The patient has the right to refuse treatment to the extent permitted by 
law, and to be informed of the medical consequences of his action. 
5. The patient has the right to every consideration of his privacy 
concerning his own medical care program. Case discussion, consultation, 
examination, and treatment are confidential and should be conducted 
discreetly. Those not directly involved in his care must have the 
permission of the patient to be present. 
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6. The patient has the right to expect that all communications and 
records pertaining to his care should be treated as confidential. 
7. The patient has the right to expect that within its capacity a hospital 
must make reasonable response to the request of a patient for services. 
The hospital must provide evaluation, service and/or referral as indicated 
by the urgency of the case. When medically permissible, a patient may be 
transferred to another facility only after he has received complete 
information and explanation concerning the needs for and alternatives to 
such a transfer. The institution to which the patient is to be transferred 
must first have accepted the patient for transfer. 
8. The patient has the right to obtain information as to any relationship of 
his hospital to other health care and educational institutions insofar as his 
care is concerned. The patient has the right to obtain information as to the 
existence of any professional relationships among individuals, by name, 
who are treating him. 
9. The patient has the right to be advised if the hospital proposes to 
engage in or perform human experimentation affecting his care or 
treatment. The patient has the right to refuse to participate in such 
research projects. 
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10. The patient has the right to expect reasonable continuity of care. He 
has the right to know in advance what appointment times and physicians 
are available and where. The patient has the right to expect that the 
hospital will provide a mechanism whereby he is informed by his physician 
or a delegate of the physician of the patient's continuing health care 
requirements following discharge. 
11. The patient has the right to examine and receive an explanation of his 
bill regardless of the source of payment. 
12. The patient has the right to know what hospital rules and regulations 
apply to his conduct as a patient. 
No catalogue of rights can guarantee for the patient the kind of treatment 
he has a right to expect. A hospital has many functions to perform, 
including the prevention and treatment of disease, the education of both 
health professionals and patients, and the conduct of clinical research. All 
these activities must be conducted with an overriding concern for the 
patient, and, above all, the recognition of his dignity as a human being.. 
Success in achieving this recognition assures success in the defense of 
the rights of the patient. 
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APPENDIX E: CODE OF NUREMBERG 
These standards of medical behavior were pronounced as part of a 
rendering of judgment against defendants at a War Crimes tribunal on 
August 19,1947, in Nurnberg, Germany. (Dunstan & Seller, 1983, 
pp.115-117) 
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THE NUREMBERG CODE 
Permissible medical experiments: 
The great weight of the evidence before us is to the effect that certain 
types of medical experiments on human beings, when kept within 
reasonably well-defined bounds, conform to the ethics of the medical 
profession generally. The protagonists of the practice of human 
experimentation justify their views on the basis that such experiments yield 
results for the good of society that are unprocurable by other methods or 
means of study. All agree, however, that certain basic principles must be 
observed in order to satisfy moral, ethical, and legal concepts: 
1. The voluntary consent of the human subject is absolutely essential. 
This means that the person involved should have legal capacity to give 
consent: should be so situated as to be able to exercise free power of 
choice, without the intervention of any element of force, fraud, deceit, 
duress, overreaching, or other ulterior form of constraint or coercion; and 
should have sufficient knowledge and comprehension of the elements of 
the subject matter involved as to enable him to make an understanding 
and enlightened decision. This latter element requires that before the 
acceptance of an affirmative decision by the experimental subject there 
should be made known to him the nature, duration, and purpose of the 
experiment; the method and means by which it is to be conducted; all 
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inconveniences and hazards reasonably to be expected; and the effects 
upon his health or person which may possibly come from his participation 
in the experiment. 
The duty and responsibility for ascertaining the quality of the consent rests 
upon each individual 
who initiates, directs, or engages in the experiment. It is a personal duty 
and responsibility which may not be delegated to another with impunity. 
2. The experiment should be such as to yield fruitful results for the good 
of society, unprocurable by other methods or means of study, and not 
random and unnecessary in nature. 
3. The experiment should be so designed and based on the results of 
animal experimentation and a knowledge of the natural history of the 
disease or other problem under study that the anticipated results justify the 
performance of the experiment. 
4. The experiment should be so conducted as to avoid all unnecessary 
physical and mental suffering and injury. 
5. No experiment should be conducted where there is an a priori reason 
to believe that death or disabling injury will occur; except, perhaps, in 
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those experiments where the experimental physicians also serve as the 
subjects. 
6. The degree of risk to be taken should never exceed that determined by 
the humanitarian importance of the problem to be solved by the 
experiment. 
7. Proper preparations should be made, and adequate facilities provided 
to protect the experimental subject against even remote possibilities of 
injury, disability, or death. 
8. The experiment should be conducted only by scientifically qualified 
persons. The highest degree of skill and care should be required through 
all stages of the experiment of those who conduct or engage in the 
experiment. 
9. During the course of the experiment the human subject should be at 
liberty to bring the experiment to an end if he has reached the physical or 
mental state where continuation of the experiment seems to him to be 
impossible. 
10. During the course of the experiment the scientist in charge must be 
prepared to terminate the experiment at any stage, if he has probable 
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cause to believe, in the exercise of the good faith, superior skill, and 
careful judgment required of him, that a continuation of the experiment is 
likely to result in injury, disability, or death to the experimental subject. 
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APPENDIX F: DECLARATION OF HELSINKI 
This Code of Ethics on Human Experimentation was originally authored by 
the World Medical Association in 1964 in a meeting in Helsinki, Finland. 
The current version of this Code - which became known as the Declaration 
of Helsinki - resulted from a revision in 1975 (Dunstan and Seller, 1983, 
pp. 118-122). 
132 
THE DECLARATION OF HELSINKI 
Recommendations guiding medical doctors in biomedical research 
involving human subjects. 
Introduction. 
It is the mission of the medical doctor to safeguard the health of the 
people. His or her knowledge and conscience are dedicated to the 
fulfillment of this mission. 
The Declaration of Geneva of the World Medical Association binds the 
doctor with the words: The health of my patient will be my first 
consideration," and the International Code of 
Medical Ethics declares that, "Any act or advice which could weaken 
physical or mental resistance of a human being may be used only in his 
interest". 
The purpose of biomedical research involving human subjects must be to 
improve diagnostic, therapeutic or prophylactic procedures and the 
understanding of the aetiology and pathogenesis of disease. 
In current medical practice most diagnostic, therapeutic or prophylactic 
procedures involve hazards. This applies a fortiori to biomedical research. 
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Medical progress is based on research which ultimately must rest in part 
on experimentation involving human subjects. In the field of biomedical 
research a fundamental distinction must be recognised between medical 
research in which the aim is essentially diagnostic or therapeutic for a 
patient, and medical research the essential object of which is purely 
scientific and without 
direct diagnostic or therapeutic value to thé person subjected to the 
research. 
Special caution must be exercised in the conduct of research which may 
effect the environment, and the welfare of animals used for research must 
be respected. 
Because it is essential that the results of laboratory experiments be 
applied to human beings to further scientific knowledge and to help 
suffering humanity, the World Medical Association has prepared the 
following recommendations as a guide to every doctor in biomedical 
research involving human subjects. They should be kept under review in 
the future. It must be stressed that the standards as drafted are only a 
guide to physicians all over the world. Doctors are not relieved from 
criminal, civil and ethical responsibilities under the laws of their own 
countries. 
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I. Basic Principles. 
1. Biomedical research involving human subjects must conform to 
generally accepted scientific principles and should be based on 
adequately performed laboratory and animal experimentation and on a 
thorough knowledge of the scientific tradition. 
2. The design and performance of each experimental procedure involving 
human subjects should be clearly formulated in an experimental protocol 
which should be transmitted to a specially appointed independent 
committee for consideration, comment, and guidance. 
3. Biomedical research involving human subjects should be conducted 
only by scientifically qualified persons and under the supervision of a 
clinically competent medical person. The responsibility for the human 
subject must always rest with a medically qualified person and never rest 
on the subject of the research, even though the subject has given his or 
her consent. 
4. Biomedical research involving human subjects cannot legitimately be 
carried out unless the 
importance of the objective is in proportion to the inherent risk to the 
subject. 
135 
5. Every biomedical research project involving human subjects should be 
preceded by careful assessment of predictable risks in comparison with 
forseeable benefits to the subject or to others. Concern for the interests of 
the subject must always prevail over the interest of science and society. 
6. The right of the research subject to safeguard his or her integrity must 
always be respected. Every precaution should be taken to respect the 
privacy of the subject and to minimise the impact of the study on the 
subject's physical and mental integrity and on the personality of the 
subject. 
7. Doctors should abstain from engaging in research projects involving 
human subjects unless they are satisfied that the hazards involved are 
believed to be predictable. Doctors should cease any investigation if the 
hazards are found to outweigh the potential benefits. 
8. In publication of the results of his or her research, the doctor is obliged 
to preserve the accuracy of the results. Reports of experimentation not in 
accordance with the principles laid down in this Declaration should not be 
accepted for publication. 
9. In any research on human beings, each potential subject must be 
adequately informed of the aims, methods, anticipated benefits and 
potential hazards of the study and the discomfort it may entail. He or she 
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should be informed that he or she is at liberty to abstain from participation 
in the study and that he or she is free to withdraw his or her consent to 
participation at any time. The doctor should then obtain the subject's 
freely-given informed consent, preferably in writing. 
10. When obtaining informed consent for the research project the doctor 
should be particularly cautious if the subject is in a dependent relationship 
to him or her or may consent under duress. In that case the informed 
consent should 
be obtained by a doctor who is not engaged in the investigation and who is 
completely independent of this official relationship. 
11. In case of legal incompetence, informed consent should be obtained 
form the legal guardian in accordance with national legislation. Where 
physical or mental incapacity makes it impossible to obtain informed 
consent, or when the subject is a minor, permission from the responsible 
relative replaces that of the subject in accordance with national legislation. 
12. The research protocol should always contain a statement of the 
ethical considerations involved and should indicate that the principles 
enunciated in the present Declaration are complied with. 
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II. Medical Research Combined with Professional Care (Clinical 
Research) 
1. In the treatment of the sick person, the doctor must be free to use a 
new diagnostic and therapeutic measure, if in his or her judgment it 
offers hope of saving life, re-establishing health or alleviating suffering. 
2. The potential benefits, hazards and discomfort of a new method 
should be weighed against the advantages of the best current diagnostic 
and therapeutic methods. 
3. In any medical study, every patient- including those of a control group, 
in any- should be assured of the best proven diagnostic and therapeutic 
method. 
4. The refusal of the patient to participate in a study must never interfere 
with the doctor-patient relationship. 
5. If the doctor considers it essential not to obtain informed consent, the 
specific reasons for this proposal should be stated in the experimental 
protocol for transmission to the independent committee. 
6. The doctor can combine medical research with professional care, the 
objective being the acquisition of new medical knowledge, only to the 
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extent that medical research is justified by its potential diagnostic or 
therapeutic value for the patient. 
III. Non-therapeutic Biomedical Research Involving Human Subjects 
(Non-Clinical Biomedical Research) 
1. In the purely scientific application of medical research carried out on a 
human being, it is the duty of the doctor to remain the protector of the life 
and health of that person on whom biomedical research is being carried 
out. 
2. The subjects should be volunteers- either healthy persons or patients-
for whom the experimental design is not related to the patient's illness. 
3. The investigator or the investigating team should discontinue if in 
his/her or their judgment it may, if continued, be harmful to the individual. 
4. In research on man, the interests of science and society should never 
take precedence over considerations related to the well-being of the 
subject. 
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APPENDIX G: PARTICIPATING TREATMENT PROGRAMS 
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Chemical dependency treatment programs involved in the study were: 
1) Powell Chemical Dependency Center (PCDC) 
Iowa Methodist Medical Center 
1200 Pleasant Street 
Des Moines, Iowa 50309 
2) Powell Chemical Dependency Center Evening Outpatient Program 
(PCDC-E) 
Iowa Methodist Medical Center 
1200 Pleasant Street 
Des Moines, Iowa 50309 
3) Center for Addictions Recovery, Inc. (CFARI) 
511 Duff Avenue 
P.O. 80x1721 
Ames, Iowa 50010 
4) Substance Abuse Treatment Center of Central Iowa (SATUCI) 
19 West State Street 
Marshalltown, Iowa 50158 
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5) Mid-Eastern Council on Chemical Abuse (MECCA) 
430 Southgate Avenue 
Iowa City, Iowa 52240 
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APPENDIX H: RATIONALE FOR CONSENT CONTENT 
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RATIONALE FOR CONSENT CONTENT 
Consent information provided to subjects in this research contained 25 
individual items. The content of consent information was developed in 
congruence with federal statute (Department of Health and Human 
Services, 1991), the Ethical Principles of Psychologists of the American 
Psychological Association (American Psychological Association, 1990), 
and regulations of the Department of Psychology and the Graduate 
College of Iowa State University A breakdown of the rationale for 
inclusion of each item follows. Material which was included in only the 
enhanced redundancy conditions appears in italics. The slight wording 
changes which were presented in the video information conditions appear 
in parentheses. In cases of specific redundancy of Federal regulations, 
professional principles, or University policies, only the Federal regulation is 
specified as the rationale for inclusion of the consent item. 
Item 1 : What is the nature of this study? 
This is a research study. Its" nature is research. 
Rationale for inclusion: 45 CFR Part 46.116(a)1, "A statement that 
the study involves research." 
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Item 2: What is the purpose of this study? 
The purpose is to study different ways of giving information to 
clients in alcohol treatment. IVe're looking at how well different ways 
of presenting information work. 
Rationale for inclusion: 45 CFR Part 46.116(a) 1, "...an explanation 
of the purposes of the research..." 
item 3: How much of my time will it take? 
Participation in this study takes about a half hour today and about 
fifteen minutes next week. Thirty minutes of your time will be needed 
today. Fifteen minutes of your time will be needed next week. 
Rationale for inclusion: 45CFR Part 46.116(a)1, "...the expected 
duration of the subject's participation..." 
Item 4: What will I have to do? 
You will be asked to read (see) this information. We'll ask you to read 
(look at) this form (video). It will take less than ten minutes. That is, 
reading it (looking at it) will take ten minutes or less. Then you will 
be asked to complete two short quizzes. Both quizzes will be rather 
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brief. Next week you'll be asked to complete another short quiz. In 
seven days we'd like you to take one more short quiz. 4 
Rationale for inclusion: 45 CFR Part 46.116(a) 1, "...a description of 
the procedures to be followed..." 
Item 5: What will the quizzes be about? 
Two of the quizzes will ask questions about this study, itself. They 
will ask questions about what you are reading (watching) right now. 
The other will be a vocabulary quiz. It will test how well you know 
words. 
Rationale for inclusion: 45 CFR Part 46.116(a)1, "...a description of 
the procedures to be followed..." 
Item 6: Are there risks or discomforts? 
Risks to you are small. This is not a very risky study. You may get 
bored or frustrated. That is, risks may include boredom and 
frustration. 
Rationale for inclusion: 45 CFR Part 46.116(a)2, "A description of 
any reasonably foreseeable risks or discomforts to the subject." 
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Item 7: What will this study help? 
This study will help us design more effective ways of presenting 
information to clients. It will help us to get information to clients 
more efficiently. 
Rationale for inclusion: 45 CFR part 46.116(a)3, "A description of 
any benefits to the subject or to others which may reasonably be 
expected from the research." 
Item 8: To what extent, if any, is my participation confidential? 
Only the tester and the project director will know that you have 
helped. Only the tester and the project director will know that you 
have been in the study. 
Rationale for inclusion: 45 CFR Part 46.116(a)5, "A statement 
describing the extent, if any, to which confidentiality of records 
identifying the subject will be maintained." 
Item 9: What will happen to the quiz and the questionnaire sheets? 
The tester will collect your quiz and questionnaire sheets. He will 
gather them up when you are done. They will be kept in a locked file 
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by the project director. He will make sure they are kept in a locked 
cabinet. 
Rationale for inclusion: 45 CFR Part 46.116(a)5, "A statement 
describing the extent, if any, to which confidentiality of records 
identifying the subject will be maintained." 
(Iowa State University) Department of 
Psychology ethical principles and policies relevant to research with 
human participants. General ethical principles. III. Confidentialitv. "...All 
nonanonymous data are to be stored in locked files to which only 
investigator-supervised, restricted access (consistent with the 
confidentiality provisions existing at the time data were collected) is 
permissible." 
Item 10: To what extent is what I tell you confidential? 
Your answers on the questionnaire and quizzes will be kept 
confidential. What you tell us will be kept private. It will not be seen 
by treatment center staff. None of the treatment center staff will have 
access to this information. 
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Rationale for inclusion: 45 CFR Part 46.116(a)5, "A statement 
describing the extent, if any, to which confidentiality of records 
identifying the subject will be maintained." 
Item 11 : Will the questionnaire and quizzes have my name on them? 
Sheets will be coded with a number, not your name. A special 
number, not your name, will be put on your answer sheets. Only the 
tester and the project director will know which sheets are yours. 
Only the tester and the project director will know which name goes 
with which number. Within a week after you finish the last quiz, the 
code numbers will be removed. In seven days or less after you 
complete the last quiz, your code numbers will be removed. 
Rationale for inclusion: 45 CFR Part 46.116(a)5, "A statement 
describing the extent, if any, to which confidentiality of records 
identifying the subject will be maintained." 
Item 12: Who can I speak to if I have questions about the study? 
If you have any questions about this study, please speak with the 
tester. If you'd like to ask about this study, please speak with the 
tester. 
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Rationale for inclusion: 45 CFR Part 46.116(a)7, "An explanation of 
whom to contact for answers to pertinent questions about the 
research..." 
American Psychological Association (1990) 
Ethical principles of psychologists. Principle 9.d, "The investigator 
informs the participants of all aspects of the research that might 
reasonably be expected to influence willingness to participate and 
explains all other aspects of the research about which the participants 
inquire." 
Item 13: Who can I speak to if I have questions about my rights? 
If you have any questions about your rights, please speak with the 
tester. If you have any questions about the treatment that you're 
entitled to, please speak with the tester. 
Rationale for inclusion: 45 CFR Part 46.116(a)7, "...and research 
subjects' rights..." 
Item 14: Who can you speak to if I feel that I have been injured? 
If you feel that you have been injured, please speak with the tester. If 
you've been hurt, please speak with the tester. 
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Rationale for inclusion: 45 CFR Part 46.116(a)7, "...and whom to 
contact in the event of a research-related injury to the subject..." 
Item 15: "How can I contact the project director?" 
You may also contact the project director at this address: 
Ken Mills 
Department of Clinical Psychology 
Iowa Methodist Medical Center 
1200 Pleasant Street 
Des Moines, Iowa 50309 
(515) 241-6834 
If you'd like to contact the project director (Ken Mills of Iowa 
Methodist Medical Center) you may do so at the above address. 
Rationale for inclusion: 45 CFR Part 46.116(a)7, "An explanation of 
whom to contact for answers to pertinent questions about the research 
and research subjects' rights, and whom to contact in the event of a 
research-related injury to the subject..." 
Item 16: "Do I have to take part in the study?" 
Taking part in the study is voluntary. You decide on your own. 
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Rationale for inclusion: 45 CFR Part 46.116(a)8, "A statement that 
participation is voluntary..." 
Item 17: Will I be penalized if you refuse to take part in the study? 
If you refuse to take part, there will be no penalty. Nothing bad will 
happen to you if you decide to not take part. 
Rationale for inclusion: 45 CFR Part 46.116(a)8, "...refusal to 
participate will involve no penalty..." 
Item 18: Will I lose any benefits if I refuse to take part in the study? 
You will not lose any benefits in the treatment program if you refuse 
to take part. You will not lose anything if you decide to not take part. 
Rationale for inclusion: 45 CFR Part 46.116(a)8, "...or loss of 
benefits to which the subject is otherwise entitled..." 
Item 19: Will I be penalized if I quit the study after I've started? 
If you quit the study after you've started, you will receive no penalty. 
Nothing bad will happen to you if you quit the study at any time. 
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Rationale for inclusion: 45 CFR Part 46.116(a)8, "...and the subject 
may discontinue participation at any time without penalty 
Item 20: Will I lose any benefits if I quit the study after I've started? 
You will not lose any benefits in the treatment program if you quit at 
any time. You will not lose anything if you decide to quit after you've 
started. 
Rationale for inclusion: 45 CFR Part 46.116(a)8, "...or loss of 
benefits to which the subject is otherwise entitled." 
Item 21: If I quit the study, what kind of reason must I give? 
If you quit the study, you need not give a reason. You don't have to 
explain to anyone if you quit the study. 
Rationale for inclusion: (Iowa State University) Department of 
PsvcholoQv ethical principles and policies relevant to research with 
human participants. General ethical principles. I. Informed consent. 
"...The participant may withdraw from a study without giving a specific 
reason for refusal to participate or for withdrawal of consent to continue 
participation." 
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Item 22: How many subjects are in this study? 
About 120 subjects are involved in this study. That is, about 120 
people will take part in the study. 
Rationale for inclusion: 45 CFR Part 46.116(b)6, "The approximate 
number of subjects involved in the study." 
Item 23: What will you tell me about the study after I finish? 
After you finish the last quiz, the tester will give you a complete 
written description of the study and will answer any questions that 
you have. As soon as you're done with the last quiz, the tester will 
hand you a printed summary of the study and will answer your 
questions. 
Rationale for inclusion: American Psychological Association (1990) 
Ethical principles of Dsvcholooists. Principle 9.h, "After the data are 
collected, the investigator provides the participant with information 
about the nature of the study and attempts to remove any 
misconceptions that may have arisen." 
Item 24: How can I find out about the final results of the study? 
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You may have a description of the results of this study sent to you. 
You can receive a report on how it comes out if you would like. If 
you would like to get a copy of these results, please tell us. If you'd 
like to know how the study comes out, let us know. 
Rationale for inclusion: American Psychological Association (1990) 
Ethical principles of psvcholoaists. Principle 9.d, "The investigator 
informs the participants of all aspects of the research that might 
reasonably be expected to influence willingness to participate and 
explains all other aspects of the research about which the participants 
inquire." 
American Psychological Association (1990) 
Ethical principles of psychologists. Principle 9.h, "After the data are 
collected, the investigator provides the participant with information 
about the nature of the study and attempts to remove any 
misconceptions that may have arisen." 
Item 25: When do you expect the study to be finished? 
We expect the study to be completed in six months or less. In half a 
year, or less, we expect the study to be finished." 
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Rationale for inclusion; American Psychological Association (1990) 
Ethical principles of psychologists. Principle 9.d, "The investigator 
informs the participants of all aspects of the research that might 
reasonably be expected to influence willingness to participate..." 
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APPENDIX I: CONSENT INFORMATION, "SIMPLE, PRINTED" 
CONDITION 
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INFORMATION SHEET 
WHAT IS THE NATURE OF THIS STUDY? 
This is a research study. 
WHAT IS THE PURPOSE OF THIS STUDY? 
The purpose is to study different ways of giving information 
to clients in alcohol treatment. 
HOW MUCH OF MY TIME WILL IT TAKE? 
Participation in this study takes about a half hour today 
and about fifteen minutes next week. 
WHAT WILL I HAVE TO DO? 
. You will be asked to read this information. It will take 
less than ten minutes. Then you will be asked to complete 
two short quizzes. Next week you'll be asked to complete 
another short quiz. 
WHAT WILL THE QUIZZES BE ABOUT? 
Two of the quizzes will ask questions about this study, 
itself. The other will be a vocabulary quiz. 
( C O N T I N U E D  O N  N E X T  P A G E )  
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(Information sheet, page 2) 
ARE THERE RISKS OR DISCOMFORTS? 
Risks to you are small. You may get bored or frustrated. 
WHAT WILL THIS STUDY HELP? 
This study will help us design more effective ways of 
presenting information to clients. 
TO WHAT EXTENT, IF ANY, IS MY PARTICIPATION CONFIDENTIAL? 
Only the tester and the project director will know that you 
have helped. 
WHAT WILL HAPPEN TO THE QUIZ AND QUESTIONNAIRE SHEETS? 
The tester will collect your quiz and questionnaire sheets. 
They will be kept in a locked file by the project director. 
TO WHAT EXTENT IS WHAT I TELL YOU CONFIDENTIAL? 
Your answers on the questionnaire and quizzes will be kept 
confidential. It will not be seen by treatment center 
staff. 
[ C O N T I N U E D  O N  N E X T  P A G E )  
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(Information sheet, page 3) 
WILL THE QUESTIONNAIRE AND QUIZZES HAVE MY NAME ON THEM? 
Sheets will be coded with a number, not your name. Only the 
tester and the project director will know which sheets are 
yours. Within a week after you finish the last quiz, the 
code numbers will be removed. 
WHO CAN I SPEAK TO IF I HAVE QUESTIONS ABOUT THE STUDY? 
If you have any questions about this study, please speak 
with the tester. 
WHO CAN I SPEAK TO IF I HAVE QUESTIONS ABOUT MY RIGHTS? 
If you have any questions about your rights, please speak 
with the tester. 
WHO CAN I SPEAK TO IF I FEEL THAT I HAVE BEEN INJURED? 
If you feel that you've been injured, please speak with the 
tester. 
( C O N T I N U E D  O N  N E X T  P A G E ]  
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(Information sheet, page 4) 
HOW CAN I CONTACT THE PROJECT DIRECTOR? 
You may also contact the project director at this address: 
Ken Mills 
Department of Clinical Psychology 
Iowa Methodist Medical Center 
1200 Pleasant Street 
Des Moines, Iowa 50309 
(515) 241-6834 
DO I HAVE TO TAKE PART IN THE STUDY? 
Taking part in the study is voluntary. 
WILL I BE PENALIZED IF I REFUSE TO TAKE PART IN THE STUDY? 
If you refuse to take part, there will be no penalty. 
WILL I LOSE ANY BENEFITS IF I REFUSE TO TAKE PART IN THE STUDY? 
You will not lose any benefits in the treatment program if 
you refuse to take part. 
WILL I BE PENALIZED IF I QUIT THE STUDY AFTER I'VE STARTED? 
If you quit the study after you've started, you will receive 
no penalty. 
( C O N T I N U E D  O N  N E X T  P A G E )  
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(Information sheet, page 5) 
WILL I LOSE ANY BENEFITS IF I QUIT THE STUDY AFTER I'VE STARTED? 
You will not lose any benefits in the treatment program if 
you quit at any time. 
IF I QUIT THE STUDY, WHAT KIND OF REASON MUST I GIVE? 
If you quit the study, you need not give a reason. 
HOW MANY SUBJECTS ARE IN THIS STUDY? 
About 120 subjects are involved in this study. 
WHAT WILL YOU TELL ME ABOUT THE STUDY AFTER I FINISH? 
After you finish the last quiz, the tester will give you a 
complete written description of the study and will answer 
any questions that you have. 
HOW CAN I FIND OUT ABOUT THE FINAL RESULTS OF THE STUDY? 
You may have a description of the results of this study sent 
to you. If you would like to get a copy of these results, 
please tell us. 
WHEN DO YOU EXPECT THE STUDY TO BE FINISHED? 
We expect the study to be completed in six months or less. 
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APPENDIX J: READABILITY ANALYSES OF PRINTED STIMULI 
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READABILITY ANALYSIS 
Readability analyses of both the simple and enhanced versions of the 
printed stimuli were completed. Analyses were performed on an Apple lie 
computer, utilizing software provided by the Heartland Area Education 
Agency, Johnston, Iowa. 
Grade Level 
Simple Printed: 
Flesch. 7.2 
Fry. 6.9 
Enhanced Printed 
Flesch. 
Fry. 
6.9 
6.7 
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APPENDIX K: CONSENT INFORMATION, "ENHANCED, PRINTED" 
CONDITION 
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INFORMATION SHEET 
WHAT IS THE NATURE OF THIS STUDY? 
This is a research study. It's nature is research. 
WHAT IS THE PURPOSE OF THIS STUDY? 
The purpose is to study different ways of giving information 
to clients in alcohol treatment. We're looking at how well 
different ways of presenting information work. 
HOW MUCH OF MY TIME WILL IT TAKE? 
Participation in this study takes about a half hour today 
and about fifteen minutes next week. Thirty minutes of your 
time will be needed today. Fifteen minutes of your time 
will be needed next week. 
WHAT WILL I HAVE TO DO? 
You will be asked to read this information. We'll ask you to 
read this form. It will take less than ten minutes. That 
is, reading it will take ten minutes or less. Then you will 
be asked to complete two short quizzes. Both quizzes will 
be rather brief. Next week you'll be asked to complete 
another short quiz. In seven days we'd like you take one 
more short quiz. 
( C O N T I N U E D  O N  N E X T  P A G E )  
( rmation sheet, page 2) 
WHAT WILL THE QUIZZES BE ABOUT? 
Two of the quizzes will ask questions about this study, 
itself. They will ask questions about what you are reading 
right now. The other will be a vocabulary quiz. It will 
test how well you know words. 
ARE THERE RISKS OR DISCOMFORTS? 
Risks to you are small. This is not a very risky study. You 
may get bored or frustrated. That is, risks may include 
boredom and frustration. 
WHAT WILL THIS STUDY HELP? 
This study will help us design more effective ways of 
presenting information to clients. It will help us to get 
information to clients more efficiently. 
TO WHAT EXTENT, IF ANY, IS MY PARTICIPATION CONFIDENTIAL? 
Only the tester and the project director will know that you 
have helped. Only the tester and the project director will 
know that you have been in the study. 
( C O N T I N U E D  O N  N E X T  P A G E )  
(iêîormation sheet, page 3) 
WHAT WILL HAPPEN TO THE QUIZ AND QUESTIONNAIRE SHEETS? 
The tester will collect your quiz and questionnaire sheets. 
He will gather them up when you are done. They will be kept 
in a locked file by the project director. He will make sure 
they are kept in a locked cabinet. 
TO WHAT EXTENT IS WHAT I TELL YOU CONFIDENTIAL? 
Your answers on the questionnaire and quizzes will be kept 
confidential. What you tell us will be kept private. It 
will not be seen by treatment center staff. None of the 
treatment center staff will have access to this information. 
WILL THE QUESTIONNAIRE AND QUIZZES HAVE MY NAME ON THEM? 
Sheets will be coded with a number, not your name. A 
special number, not your name, will be put on your answer 
sheets. Only the tester and the project director will know 
which sheets are yours. Only the tester and the project 
director will know which name goes with which number. 
Within a week after you finish the last quiz, the code 
numbers will be removed. In seven days or less after you 
complete the last quiz, your code numbers will be removed. 
( C O N T I N U E D  O N  N E X T  P A G E )  
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(Information sheet, page 4) 
WHO CAN I SPEAK TO IF I HAVE QUESTIONS ABOUT THE STUDY? 
If you have any questions about this study, please speak 
with the tester. If you'd like to ask about this study, 
please speak with the tester. 
WHO CAN I SPEAK TO IF I HAVE QUESTIONS ABOUT MY RIGHTS? 
If you have any questions about your rights, please speak 
with the tester. If you have any questions about the 
treatment that you're entitled to, please speak with the 
tester. 
WHO CAN I SPEAK TO IF I FEEL THAT I HAVE BEEN INJURED? 
If you feel that you've been injured, please speak with the 
tester. If you've been hurt, please speak with the tester. 
HOW CAN I CONTACT THE PROJECT DIRECTOR? 
You may also contact the project director at this address: 
Ken Mills 
Department of Clinical Psychology 
Iowa Methodist Medical Center 
1200 Pleasant Street 
Des Moines, Iowa 50309 
(515) 241-6834 
( C O N T I N U E D  O N  N E X T  P A G E )  
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(Information sheet, page 5) 
If you'd like to contact the project director (Ken Mills of 
Iowa Methodist Medical Center) you may do so at the above 
address. 
DO I HAVE TO TAKE PART IN THE STUDY? 
Taking part in the study is voluntary. You decide on your 
own, 
WILL I BE PENALIZED IF I REFUSE TO TAKE PART IN THE STUDY? 
If you refuse to take part, there will be no penalty. 
Nothing bad will happen to you if you decide to not take 
part. 
WILL I LOSE ANY BENEFITS IF I REFUSE TO TAKE PART IN THE STUDY? 
You will not lose any benefits in the treatment program if 
you refuse to take part. You will not lose anytyhing if you 
decide to not take part. 
WILL I BE PENALIZED IF I QUIT THE STUDY AFTER I'VE STARTED? 
If you quit the study after you've started, you will receive 
no penalty. Nothing bad will happen to you if you quit the 
study at any time. 
C C O N T I N U E D  O N  N E X T  P A G E ]  
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(Information sheet, page 6) 
WILL I LOSE ANY BENEFITS IF I QUIT THE STUDY AFTER I'VE STARTED? 
You will not lose any benefits in the treatment program if 
you quit at any time. You will not lose anytyhing if you 
decide to quit after you've started. 
IF I QUIT THE STUDY, WHAT KIND OF REASON MUST I GIVE? 
If you quit the study, you need not give a reason. You 
don't have to explain to anyone if you quit the study. 
HOW MANY SUBJECTS ARE IN THIS STUDY? 
About 120 subjects are involved in this study. That is, 
about 120 people will take part in the study. 
WHAT WILL YOU TELL ME ABOUT THE STUDY AFTER I FINISH? 
After you finish the last quiz, the tester will give you a 
complete written description of the study and will answer 
any questions that you have. As soon as you're done with 
the last quiz, the tester will hand you a printed summary of 
the study and will answer your questions. 
( C O N T I N U E D  O N  N E X T  P A G E )  
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(Information sheet, page 7) 
HOW CAN I FIND OUT ABOUT THE FINAL RESULTS OF THE STUDY? 
You may have a description of the results of this study sent 
to you. You can receive a report on how it comes out if you 
would like. If you would like to get a copy of these 
results, please tell us. If you'd like to know how the 
study comes out, let us know. 
WHEN DO YOU EXPECT THE STUDY TO BE FINISHED? 
We expect the study to be completed in six months or less. 
In half a year, or less, we expect the study to be finished. 
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APPENDIX L: CONSENT INFORMATION, "SIMPLE, VIDEO" 
CONDITION 
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TEXT OF "SIMPLE, VIDEO" CONDITION. 
(This text will be read by the actors in the video format presentation. The 
content is virtually identical with that of the "Simple, Printed" condition, 
with the exception of references to hearing the information, rather than 
reading it..) 
OFF CAMERA VOICE: WHAT IS THE NATURE OF THIS STUDY? 
ANNOUNCER; This is a research study. 
OFF CAMERA VOICE: WHAT IS THE PURPOSE OF THIS STUDY? 
ANNOUNCER: The purpose is to study different ways of giving 
information to clients in alcohol treatment. 
OFF CAMERA VOICE: HOW MUCH OF MY TIME WILL IT TAKE? 
ANNOUNCER: Participation in this study takes about a half hour 
today and about fifteen minutes next week. 
OFF CAMERA VOICE: WHAT WILL I HAVE TO DO? 
ANNOUNCER: You will be asked to hear this information. It will take 
less than ten minutes. Then you will be asked to complete two short 
quizzes. Next week you'll be asked to complete another short quiz. 
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OFF CAMERA VOICE: WHAT WILL THE QUIZZES BE ABOUT? 
ANNOUNCER: Two of the quizzes will ask questions about this study, 
itself. The other will be a vocabulary quiz. 
OFF CAMERA VOICE: ARE THERE RISKS OR DISCOMFORTS? 
ANNOUNCER: Risks to you are small. You may get bored or 
frustrated. 
OFF CAMERA VOICE: WHAT WILL THIS STUDY HELP? 
ANNOUNCER: This study will help us design more effective ways of 
presenting information to clients. 
OFF CAMERA VOICE: TO WHAT EXTENT, IF ANY, IS MY 
PARTICIPATION CONFIDENTIAL? 
ANNOUNCER: Only the tester and the project director will know that 
you have helped. 
OFF CAMERA VOICE: WHAT WILL HAPPEN TO THE QUIZ AND 
QUESTIONNAIRE SHEETS? 
ANNOUNCER: The tester will collect your quiz and questionnaire 
sheets. They will be kept in a locked file by the project director. 
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OFF CAMERA VOICE; TO WHAT EXTENT IS WHAT I TELL YOU 
CONFIDENTIAL? 
ANNOUNCER: Your answers on the questionnaire and quizzes will 
be kept confidential. They will not be seen by treatment center staff. 
OFF CAMERA VOICE: WILL THE QUESTIONNAIRE AND QUIZZES 
HAVE MY NAME ON THEM? 
ANNOUNCER: Sheets will be coded with a number, not your name. 
Only the tester and the project director will know which sheets are yours. 
Within a week after you finish the last quiz, the code numbers will be 
removed. 
OFF CAMERA VOICE: WHO CAN I SPEAK TO IF I HAVE 
QUESTIONS ABOUT THE STUDY? 
ANNOUNCER: If you have any questions about this study, please 
speak with the tester. 
OFF CAMERA VOICE: WHO CAN I SPEAK TO IF I HAVE 
QUESTIONS ABOUT MY RIGHTS? 
ANNOUNCER: If you have any questions about your rights, please 
speak with the tester. 
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OFF CAMERA VOICE; WHO CAN I SPEAK TO IF I FEEL THAT I 
HAVE BEEN INJURED? 
ANNOUNCER: If you feel that you've been injured, please speak with 
the tester. 
OFF CAMERA VOICE: HOW CAN I CONTACT THE PROJECT 
DIRECTOR? 
ANNOUNCER: You may also contact the project director at this 
address: 
Ken Mills 
Department of Clinical Psychology 
Iowa Methodist Medical Center 
1200 Pleasant Street 
Des Moines, Iowa 50309 
(515)241-6834 
OFF CAMERA VOICE: DO I HAVE TO TAKE PART IN THE STUDY? 
ANNOUNCER: Taking part in the study is voluntary. 
OFF CAMERA VOICE: WILL I BE PENALIZED IF I REFUSE TO TAKE 
PART IN THE STUDY? 
ANNOUNCER: If you refuse to take part, there will be no penalty. 
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OFF CAMERA VOICE: WILL I LOSE ANY BENEFITS IF I REFUSE 
TO TAKE PART IN THE STUDY? 
ANNOUNCER: You will not lose any benefits in the treatment 
program if you refuse to take part. 
OFF CAMERA VOICE: WILL I BE PENALIZED IF I QUIT THE STUDY 
AFTER I'VE STARTED? 
ANNOUNCER: If you quit the study after you've started, you will 
receive no penalty. 
OFF CAMERA VOICE: WILL I LOSE ANY BENEFITS IF I QUIT THE 
STUDY AFTER I'VE STARTED? 
ANNOUNCER: You will not lose any benefits in the treatment 
program if you quit at any time. 
OFF CAMERA VOICE: IF I QUIT THE STUDY. WHAT KIND OF 
REASON MUST I GIVE? 
ANNOUNCER: If you quit the study, you need not give a reason. 
OFF CAMERA VOICE: HOW MANY SUBJECTS ARE IN THIS 
STUDY? 
ANNOUNCER: About 120 subjects are involved in this study. 
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OFF CAMERA VOICE: WHAT WILL YOU TELL ME ABOUT THE 
STUDY AFTER I FINISH? 
ANNOUNCER: After you finish the last quiz, the tester will give you a 
complete written description of the study and will answer any questions 
that you have. 
OFF CAMERA VOICE: HOW CAN I FIND OUT ABOUT THE FINAL 
RESULTS OF THE STUDY? 
ANNOUNCER: You may have a description of the results of this study 
sent to you. If you would like to get a copy of these results, please tell us. 
OFF CAMERA VOICE: WHEN DO YOU EXPECT THE STUDY TO BE 
FINISHED? 
ANNOUNCER: We expect the study to be completed in six months or 
less. 
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CONDITION 
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TEXT OF "ENHANCED, VIDEO" CONDITION. 
(This text is read by the actors in the video format presentation. The 
content is virtually identical with that of the "Enhance, Printed" condition, 
with the exception of references to hearing the information, rather than 
reading it.) 
OFF CAMERA VOICE: WHAT IS THE NATURE OF THIS STUDY? 
ANNOUNCER: This is a research study. It's nature is research. 
OFF CAMERA VOICE: WHAT IS THE PURPOSE OF THIS STUDY? 
ANNOUNCER: The purpose is to study different ways of giving 
information to clients in alcohol treatment. We're looking at how well 
different ways of presenting information work. 
OFF CAMERA VOICE: HOW MUCH OF MY TIME WILL IT TAKE? 
ANNOUNCER: Participation in this study takes about a half hour 
today and about fifteen minutes next week. Thirty minutes of your time will 
be needed today. Fifteen minutes of your time will be needed next week. 
OFF CAMERA VOICE: WHAT WILL I HAVE TO DO? 
ANNOUNCER: You will be asked to hear this information. We'll ask 
you to listen to this presentation. It will take less than ten minutes. That 
is, listening to it will take ten minutes or less. Then you will be asked to 
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complete two short quizzes. Both quizzes will be rather brief. Next week 
you'll be asked to complete another short quiz. In seven days we'd like 
you take one more short quiz. 
OFF CAMERA VOICE: WHAT WILL THE QUIZZES BE ABOUT? 
ANNOUNCER: Two of the quizzes will ask questions about this study, 
itself. They will ask questions about what you are reading right now. The 
other will be a vocabulary quiz. It will test how well you know words. 
OFF CAMERA VOICE: ARE THERE RISKS OR DISCOMFORTS? 
ANNOUNCER: Risks to you are small. This is not a very risky study. 
You may get bored or frustrated. That is, risks may include boredom and 
frustration. 
OFF CAMERA VOICE: WHAT WILL THIS STUDY HELP? 
ANNOUNCER: This study will help us design more effective ways of 
presenting information to clients. It will help us to get information to clients 
more efficiently. 
OFF CAMERA VOICE: TO WHAT EXTENT, IF ANY, IS MY 
PARTICIPATION CONFIDENTIAL? 
ANNOUNCER: Only the tester and the project director will know that 
you have helped. Only the tester and the project director will know that 
you have been in the study. 
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OFF CAMERA VOICE; WHAT WILL HAPPEN TO THE QUIZ AND 
QUESTIONNAIRE SHEETS? 
ANNOUNCER: The tester will collect your quiz and questionnaire 
sheets. He will gather them up when you are done. They will be kept in a 
locked file by the project director. He will make sure they are kept in a 
locked cabinet. 
OFF CAMERA VOICE: TO WHAT EXTENT IS WHAT I TELL YOU 
CONFIDENTIAL? 
ANNOUNCER: Your answers on the questionnaire and quizzes will 
be kept confidential. What you tell us will be kept private. It will not be 
seen by treatment center staff. None of the treatment center staff will 
have access to this information. 
OFF CAMERA VOICE: WILL THE QUESTIONNAIRE AND QUIZZES 
HAVE MY NAME ON THEM? 
ANNOUNCER: Sheets will be coded with a number, not your name. A 
special number, not your name, will be put on your answer sheets. Only 
the tester and the project director will know which sheets are yours. Only 
the tester and the project director will know which name goes with which 
number. Within a week after you finish the last quiz, the code numbers 
will be removed. In seven days or less after you complete the last quiz, 
your code numbers will be removed. 
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OFF CAMERA VOICE: WHO CAN I SPEAK TO IF I HAVE 
QUESTIONS ABOUT THE STUDY? 
ANNOUNCER: If you have any questions about this study, please 
speak with the tester. If you'd like to ask about this study, please speak 
with the tester. 
OFF CAMERA VOICE: WHO CAN I SPEAK TO IF I HAVE 
QUESTIONS ABOUT MY RIGHTS? 
ANNOUNCER: If you have any questions about your rights, please 
speak with the tester. If you have any questions about the treatment that 
you're entitled to, please speak with the tester. 
OFF CAMERA VOICE: WHO CAN I SPEAK TO IF I FEEL THAT I 
HAVE BEEN INJURED? 
ANNOUNCER: If you feel that you've been injured, please speak with 
the tester. If you've been hurt, please speak with the tester. 
OFF CAMERA VOICE: HOW CAN I CONTACT THE PROJECT 
DIRECTOR? 
ANNOUNCER: You may also contact the project director at this 
address: 
Ken Mills 
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Department of Clinical Psychology 
Iowa Methodist Medical Center 
1200 Pleasant Street 
Des Moines, Iowa 50309 
(515) 241-6834 
If you'd like to contact the project director (Ken Mills of Iowa Methodist 
Medical Center) you may do so at the above address. 
OFF CAMERA VOICE; DO I HAVE TO TAKE PART IN THE STUDY? 
ANNOUNCER: Taking part in the study is voluntary. You decide on 
your own. 
OFF CAMERA VOICE: WILL I BE PENALIZED IF I REFUSE TO TAKE 
PART IN THE STUDY? 
ANNOUNCER: If you refuse to take part, there will be no penalty. 
Nothing bad will happen to you if you decide to not take part. 
OFF CAMERA VOICE: WILL I LOSE ANY BENEFITS IF I REFUSE 
TO TAKE PART IN THE STUDY? 
ANNOUNCER: You will not lose any benefits in the treatment 
program if you refuse to take part. You will not lose anything if you decide 
to not take part. 
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OFF CAMERA VOICE: WILL I BE PENALIZED IF I QUIT THE STUDY 
AFTER I'VE STARTED? 
ANNOUNCER: If you quit the study after you've started, you will 
receive no penalty. Nothing bad will happen to you if you quit the study at 
any time. 
OFF CAMERA VOICE: WILL I LOSE ANY BENEFITS IF I QUIT THE 
STUDY AFTER I'VE STARTED? 
ANNOUNCER: You will not lose any benefits in the treatment 
program if you quit at any time. You will not lose anything if you decide to 
quit after you've started. 
OFF CAMERA VOICE: IF I QUIT THE STUDY, WHAT KIND OF 
REASON MUST I GIVE? 
ANNOUNCER: If you quit the study, you need not give a reason. You 
don't have to explain to anyone if you quit the study. 
OFF CAMERA VOICE: HOW MANY SUBJECTS ARE IN THIS 
STUDY? 
ANNOUNCER: About 120 subjects are involved in this study. That is, 
about 120 people will take part in the study. 
OFF CAMERA VOICE: WHAT WILL YOU TELL ME ABOUT THE 
STUDY AFTER I FINISH? 
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ANNOUNCER: After you finish the last quiz, the tester will give you a 
complete written description of the study and will answer any questions 
that you have. As soon as you're done with the last quiz, the tester 
will hand you a printed summary of the study and will answer your 
questions. 
OFF CAMERA VOICE: HOW CAN I FIND OUT ABOUT THE FINAL 
RESULTS OF THE STUDY? 
ANNOUNCER: You may have a description of the results of this study 
sent to you. You can receive a report on how it comes out if you would 
like. If you would like to get a copy of these results, please tell us. If you'd 
like to know how the study comes out, let us know. 
OFF CAMERA VOICE: WHEN DO YOU EXPECT THE STUDY TO BE 
FINISHED? 
ANNOUNCER: We expect the study to be completed in six months or 
less. In half a year, or less, we expect the study to be finished. 
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Agreement to Participate in this Study; 
Your signature below indicates that you have read and 
understood the information form and that you voluntarily 
agree to participate in the study described. 
Signature of Participant Date 
Signature of Witness D a t e  
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APPENDIX O: CONSENT SIGNOFF, VIDEO CONDITIONS 
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Agreement to Participate in this Study; 
Your signature below indicates that you have seen, 
heard, and understood the presentation of information and 
that you voluntarily agree to participate in the study 
described. 
Signature of Participant Date 
Signature of Witness Date 
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APPENDIX P: COMPLETE DESCRIPTION OF STUDY 
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COMPLETE DESCRIPTION OF STUDY 
This was a research study about the effectiveness of different ways of 
presenting information to clients in alcohol treatment. We compared 
written material and video material. Also, we looked at the effect of 
repeated information. To help in this study took about a half hour on the 
first day and about fifteen minutes a week later. 
Subjects were asked to either read some information or watch a video. 
Each took less than ten minutes. Then they were asked to complete two 
short quizzes. One of the quizzes asked questions about this study, itself. 
The other was a vocabulary quiz. Seven days later, subjects were asked 
to complete another short quiz. The quizzes on the first day were given by 
Ken Mills, who was also the project director. 
The vocabulary quiz helped us to be aware of any reading problems 
that the subjects might have. These problems could have influenced their 
responses on the other quizzes. Subjects' responses on the other quizzes 
gave us a measure of how effective the presentation of information was. 
Risks to subjects were small. You might have been bored or 
frustrated. 
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The tester collected the test sheets after each testing session was 
done. They are kept in a locked file cabinet by the project director. 
This research will help us design more effective ways of presenting 
information to clients. 
All answers on the quizzes will be kept confidential. Sheets will be 
coded with a number, not your name. Only the project director will know 
which numbers go with which names. Within a week from the time you 
finish the last quiz, the numbers will be removed. After that, no one at all 
will be able to tell which sheets are yours. 
If you have further questions about this study, your rights, or if you feel 
that you've been injured, please speak with the tester. You may contact 
the project director at this address: 
Kenneth R. Mills 
Department of Clinical Psychology 
Iowa Methodist Medical Center 
1200 Pleasant Street 
Des Moines, Iowa 50309 
(515) 241-6834 
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Your participation has been voluntary and has not affected your 
relationship with staff of the treatment center. Your treatment will not be 
affected in any way. You will not gain or lose any privileges. 
Please do not discuss this study with the other clients in treatment. If 
people know the content of the study before they participate, the results 
could be affected. 
You may have a description of the results of this study sent to you. If 
you would like a copy, please give your name and address to the tester. It 
will be given to the project director and you will be sent a copy of the 
results when the study is finished. We expect the research to be 
completed in six months or less. 
Thank you for your help! 
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"The effect of information redundancy and format." 
Your signature below indicates that you have read and understood the 
information form and that you voluntarily agree to participate in the study 
described. 
Signature of Participant Date 
You are entitled to a general description of the results of this study. If 
you would like to receive a copy of these results, please print your name 
and address below. A description of our findings will be sent to you upon 
completion of this study (in about six months from now, or less). 
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APPENDIX Q: DEMOGRAPHIC QUESTIONNAIRE AND INFORMED 
CONSENT QUIZ 
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QUESTIONNAIRE 
DO NOT WRITE YOUR NAME ON THIS OR ANY OTHER SHEET! 
What is today's date? 
When did you enter treatment? 
Are you in treatment for alcohol? Other drugs? 
How long has it been since you've had a drink? 
Did you go through detoxification? 
If so, when did you complete detox? 
Are you taking any detox medication, other than vitamins? 
If so, what? 
How far did you go in school? 
Do you have a G.E.D.? 
What is your gender? (circle one) male female 
What is your birth date? (month, year, and date) 
Do you have any difficulty in hearing? 
If so, how bad is it? 
Do you have any trouble with your vision? 
If so, what is the trouble? 
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QUIZ 
1) WHAT IS THE NATURE OF THIS STUUY? 
2) WHAT IS THE PURPOSE OF THIS STUDY? 
3) HOW MUCH OF YOUR TIME WILL IT TAKE? 
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(Quiz, page 3) 
4) WHAT WILL YOU HAVE TO DO? 
5) WHAT WILL THE QUIZZES BE ABOUT? 
6) ARE THERE RISKS OR DISCOMFORTS? 
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(Quiz, page 4) 
7) WHAT WILL THIS STUDY HELP? 
8) TO WHAT EXTENT, IF ANY, IS YOUR PARTICIPATION 
CONFIDENTIAL? 
9) WHAT WILL HAPPEN TO THE QUIZ AND QUESTIONNAIRE SHEETS? 
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(Quiz, page 5) 
10) TO WHAT EXTENT IS WHAT YOU TELL US CONFIDENTIAL? 
11) WILL THE QUESTIONNAIRE AND QUIZZES HAVE YOUR NAME ON 
THEM? 
12) WHO CAN YOU SPEAK TO IF YOU HAVE QUESTIONS AUOUT THE 
STUDY? 
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(Quiz, page 6) 
13) WHO CAN YOU SPEAK TO IF YOU HAVE QUESTIONS ABOUT YOUR 
RIGHTS? 
14) WHO CAN YOU SPEAK TO IF YOU FEEL THAT YOU HAVE BEEN 
INJURED? 
15) HOW CAN YOU CONTACT THE PROJECT DIRECTOR? 
(Quiz, page 7) 
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16) DO YOU HAVE TO TAKE PART IN THE STUDY? 
17) WILL YOU BE PENALIZED IF YOU REFUSE TO TAKE PART IN THE 
STUDY? 
1 8 )  WILL YOU LOSE ANY BENEFITS IF ÏOU REFUSE TO TAKE PARI IN 
THE STUDY? 
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(Quiz, page 8) 
19) WILL YOU BE PENALIZED IF YOU QUIT THE STUDY AFTER YOU'VE 
STARTED? 
20) WILL YOU LOSE ANY BENEFITS IF YOU QUIT THE STUDY AFTER 
YOU'VE STARTED? 
21) IF YOU QUIT THE STUDY, WHAT KIND OF REASON MUST YOU GIVE? 
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(Quiz, page 9) 
22) HOW MANY SUBJECTS ARE IN THIS STUDY? 
23) WHAT WILL WE TELL YOU ABOUT THE STUDY AFTER YOU FINISH? 
24) HOW CAN YOU FIND OUT ABOUT THE FINAL RESULTS OF THE 
STUDY? 
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(Quiz, page 10) 
25) WHEN DO WE EXPECT THE STUDY TO BE FINISHED? 
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APPENDIX R: SCORING CRITERIA, INFORMED CONSENT QUIZ 
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SCORING THE INFORMED CONSENT QUIZ 
The purpose of consent information is to convey to the subject an 
understanding of salient aspects of the study. With that in mind, both the 
initial questionnaire and the posttest were constructed in a short answer 
format. This format does not reflect an emphasis upon rote memory, 
instead allowing the subject to describe his or her understanding of the 
information in his or her own words. Consequently, the adequacy of 
individual responses was not adjudged based upon the degree of verbatim 
restatement of the stimulus material. Rather, responses were evaluated 
based upon the understanding they reflected of the particular article of 
information involved. 
The quiz ( was constructed of 25 questions, containing a total of 30 
scorabie points. Each question was followed by 5 blank lines, allowing the 
subject adequate room to answer the question as fully or as briefly as 
desired. 
Scoring Criteria 
Question 1 : "What is the nature of this study?" 
Relevant stimulus material (enhanced stimulus material appears in italics): 
"This is a research study. Its" nature is research" 
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Credit was given for use of the word "research" in describing the study or a 
general description of the activity as a scientific endeavor, studying 
communication. Credit was not given for answers which stated or implied 
that the study was part of the treatment regimen.Question 2: "What is 
the purpose of this study?" 
Relevant stimulus material: "The purpose is to study different ways of 
giving information to clients in alcohol treatment. We're looking at how 
well different ways of presenting information work." 
Credit was given for answers which described the purpose of the study as 
the examination of different ways of presenting information, or studying 
communication with clients. Credit was not given for answers which 
stated or implied that the purpose of the study was to improve clinical 
treatment. 
Question 3: "How much of your time will it talce?" 
Relevant stimulus material: "Participation in this study takes about a half 
hour today and about fifteen minutes next week. Thirty minutes of your 
time will be needed today. Fifteen minutes of your time will be needed 
next week." 
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This question was allotted two points: one point for the statement of the 
thirty minute interval during the first meeting and one point for the 
statement of the fifteen minute inten/al during the second session. 
One credit was given for responses mentioning only the initial thirty 
minute session or stating that the overall duration of both session would 
be forty five minutes. Two credits were given to responses which 
specified the duration of both the initial and posttest sessions. No credit 
was given for responses which specified inaccurate durations or 
generalities. 
Question 4: "What will you have to do?" 
Relevant stimulus material (video statements in parentheses): "You will 
be asked to read (see) this information. We'll ask you to read (look at) this 
form (video). It will take less than ten minutes. That is, reading it (looking 
at it) will take ten minutes or less. Then you will be asked to complete two 
short quizzes. Both quizzes will be rather brief. Next week you'll be asked 
to complete another short quiz. In seven days we'd like you to take one 
more short quiz. 
Question 4 was allotted three points: one point for the required activity of 
reading the form, or watching the video; one point for the two required 
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quizzes during the first session; and one point for the single required quiz 
during the second session. 
One point was given for mention of each of the required activities. 
Answers which stated only the total number of tests across both sessions 
received only one point for that portion of the answer. Answers which 
stated only that tests would be answered, without specifying a number, 
received no point for that portion of the answer. 
Question 5: "What will the quizzes be about?" 
Relevant stimulus material: "Two of the quizzes will ask questions about 
this study, itself. They will ask questions about what you are reading 
(watching) right now. The other will be a vocabulary quiz. It will test how 
well you know words. 
Two credits were allotted to question 5. One credit was given for mention 
of each of the two quiz categories. Credit was not given for generalities or 
answers which stated or implied that the quizzes were clinical in nature. 
Question 6: "Are there risks or discomforts?" 
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Relevant stimulus material: "Risks to you are small. This is not a very 
risi<y study. You may get bored or frustrated. That is, risks may include 
boredom and frustration. 
One credit was given for answers which specified minor risks or which 
described the study as only minimally risky. Credit was not given for 
answers which stated that there were no risks at all involved in the study. 
Question 7: "What will this study help?" 
Relevant stimulus material: "This study will help us design more effective 
ways of presenting information to clients. It will help us to get information 
to clients more efficiently." 
One point credit was given for responses which described a facilitation of 
communication with clients. General statements^ such as "help out in 
treatment" were given no credit. 
Question 8: To what extent, if any, is your participation 
confidential?" 
Relevant stimulus material: "Only the tester and the project director will 
know that you have helped. Only the tester and the project director will 
know that you have been in the study.." 
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One point credit was assigned to responses which described either a 
limitation of knowledge of participation to the tester and the project 
director, or substantial confidentiality regarding participation. General 
statements, such as "100% confidential", were accepted. Since for all of 
the subjects the tester was also the project director, a statement that 
knowledge of participation was limited to either party was acceptable. 
Question 9: "What will happen to the quiz and the questionnaire 
sheets?" 
Relevant stimulus material: "The tester will collect your quiz and 
questionnaire sheets. He will gather them up when you are done. They 
will be kept in a locked file by the project director. He will make sure they 
are kept in a locked cabinet." 
Although the information given in the stimulus material relevant to this 
topic is rather specific, the question itself is quite general in nature. 
Therefore, one credit was given for responses which accurately described 
procedures to be undertaken with the quiz and questionnaire sheets. 
Accepted responses included, but were not limited to: "Locked up", "be 
analyzed", "be studied, then destroyed", and "be reviewed by the project 
director." Responses which stated or implied that the quiz and 
questionnaire sheets would be reviewed by treatment staff, or other 
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individuals beyond the described limits of confidentiality, were given no 
credit. 
Question 10: "To what extent is what you tell us confidential?" 
Relevant stimulus material; "Your answers on the questionnaire and 
quizzes will be kept confidential. What you tell us will be kept private. It 
will not be seen by treatment center staff. None of the treatment center 
staff will have access to this information." 
As in Question 8, one point credit was assigned to responses which 
described either a limitation of knowledge of participation to the tester and 
the project director, or substantial confidentiality regarding participation. 
General statements, such as "100% confidential", were accepted. Since 
for all of the subjects the tester was also the project director, a statement 
that knowledge of participation was limited to either party was acceptable. 
Responses which stated or implied that treatment center staff would have 
access to the quiz and questionnaire sheets were given no credit. 
Question 11: "Will the questionnaire and quizzes have your name on 
them?" 
Relevant stimulus material: "Sheets will be coded with a number, not your 
name. A spedal number, not your name, will be put on your answer 
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sheets. Only the tester and the project director will know which sheets are 
yours. Only the tester and the project director will know which name goes 
with which number. Within a week after you finish the last quiz, the code 
numbers will be removed. In seven days or less after you complete the 
last quiz, your code numbers will be removed." 
One point credit was given to responses which accurately stated that 
subject names would not appear on the quiz and questionnaire sheets. 
Question 12: "Who can you speak to if you have questions about the 
study?" 
Relevant stimulus material: "If you have any questions about this study, 
please speak with the tester. If you'd like to ask about this study, please 
speak with the tester." 
One credit was given for responses which indicated that subjects could 
query the tester regarding aspects of the study. Since for all subjects, at 
the time of the initial testing, the tester was also the project director, a 
statement that questions could be directed to the project director was also 
acceptable. Responses which indicated that treatment counselors or 
hospital administrators could be asked about the study were not given 
credit. 
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Question 13: "Who can you speak to if you have questions about 
your rights?" 
Relevant stimulus material: "If you have any questions about your rights, 
please speak with the tester. If you have any questions about the 
treatment that you're entitled to, please speak with the tester" 
One credit was given for responses which indicated that subjects could 
query the tester regarding their rights. Since for all subjects, at the time of 
the initial testing, the tester was also the project director, a statement that 
questions could be directed to the project director was also acceptable. 
Responses which indicated that treatment counselors, hospital 
administrators, or attorneys could be queried were given no credit. 
Question 14: "Who can you speak to if you feel that you have been 
injured?" 
Relevant stimulus material: "If you feel that you have been injured, please 
speak with the tester. If you've been hurt, please speak with the tester." 
One credit was given for responses which indicated that subjects could 
speak with the tester regarding possible injury. Since for all subjects, at 
the time of the initial testing, the tester was also the project director, a 
statement that subjects could speak with the project director was also 
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acceptable. Responses which indicated other resources in case of 
possible injury, such as attorneys, while ostensibly accurate, did not reflect 
an accurate understanding of the presented material and were given no 
credit. 
Question 15: "How can you contact the project director?" 
Relevant stimulus material: "You may also contact the project director at 
this address; 
Ken Mills 
Department of Clinical Psychology 
Iowa Methodist Medical Center 
1200 Pleasant Street 
Des Moines, Iowa 50309 
(515)241-6834 
If you'd like to contact the project director (Ken Mills of Iowa Methodist 
Medical Center) you may do so at the above address." 
Two points of credit were assigned to this question. One point was given 
if the name of the project director, or his identity as the tester, was stated. 
No credit for identity was given if only a first name was referenced. An 
additional point was given if an element of his address was accurately 
stated (e.g., Iowa Methodist Medical Center, phone number). If the 
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subject was tested at Iowa Methodist Medical Center, a statement that the 
director could be contacted "here" was acceptable. General responses, 
such as "by phone", or "at his office", or "in Des Moines" were not given 
credit. 
Question 16: "Do you have to take part in the study?" 
Relevant stimulus material: "Taking part in the study is voluntary. You 
decide on your own. " 
One point of credit was given for responses which indicated a recognition 
of the voluntary nature of participation in the study. 
Question 17: "Will you be penalized if you refuse to take part in the 
study?" 
Relevant stimulus material: "If you refuse to take part, there will be no 
penalty. Nothing bad will happen to you if you decide to not take part." 
One point of credit was given for responses which indicated a recognition 
that no penalty would be imposed for refusal to participate. 
Question 18: "Will you lose any benefits if you refuse to take part in 
the study?" 
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Relevant stimulus material: "You will not lose any benefits in the treatment 
program if you refuse to take part. You will not lose anything if you decide 
to not take part." 
One point of credit was given for responses which indicated a recognition 
that no benefits would be lost as a result of refusal to participate in the 
study. 
Question 19: "Will you be penalized if you quit the study after you've 
started?" 
Relevant stimulus material: "If you quit the study after you've started, you 
will receive no penalty. Nothing bad will happen to you if you quit the 
study at any time." 
One point of credit was given for responses which indicated a recognition 
that no penalty would be meted out to subjects as a result of quitting the 
study before completion. 
Question 20: "Will you lose any benefits if you quit the study after 
you've started?" 
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Relevant stimulus material; "You will not lose any benefits in the treatment 
program if you quit at any time. You will not lose anything if you decide to 
quit after you've started." 
One point of credit was given for responses which indicated a recognition 
that no benefit to subjects would be withheld or withdrawn as a result of 
quitting the study before completion. 
Question 21: "If you quit the study, what kind of reason must you 
give?" 
Relevant stimulus material: "If you quit the study, you need not give a 
reason. You don't have to explain to anyone if you quit the study." 
One point of credit was given for responses which indicated a recognition 
that subjects could quit the study without giving a reason. 
Question 22: "How many subjects are in this study?" 
Relevant stimulus material: "About 120 subjects are involved in this study. 
That is, about 120 people will take part in the study." 
One point of credit was given only for responses which accurately 
specified the number of subjects to be 120. (Although in the final design, 
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the number of subjects was somewhat fewer than 120, this number was 
presented to all subjects as part of the stimulus material in order to 
maintain uniformity. At the time of full debriefing, subjects were informed 
of the smaller number of subjects expected to participate in the study.) 
Question 23: "What will we tell you about the study after you 
finish?" 
Relevant stimulus material; "After you finish the last quiz, the tester will 
give you a complete written description of the study and will answer any 
questions that you have. As soon as you're done with the last quiz, the 
tester will hand you a printed summary of the study and will answer your 
questions." 
One point of credit was given for responses which indicated a recognition 
that a complete description of the study would be provided upon 
completion of subject participation, and/or that any subject questions 
about the study would be answered. Credit was not given for responses 
that indicated that the results of the study would be forthcoming 
immediately after the subject had completed his or her participation. 
Question 24: "How can you find out about the final results of the 
study?" 
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Relevant stimulus material: "You may have a description of the results of 
this study sent to you. You can receive a refDort on how it conries out if you 
would like. If you would like to get a copy of these results, please tell us. 
If you'd like to know how the study comes out, let us know. " 
One point of credit was given to responses which indicated that the results 
of the study would be sent if requested. No credit was given to responses 
which stated that the results would be sent automatically. 
Question 25: "When do we expect the study to be finished?" 
Relevant stimulus material: "We expect the study to be completed in six 
months or less. In half a year, or less, we expect the study to be finished. " 
One point of credit was given to responses specifying that the study would 
be completed in six months, or less, or that it would be completed in six 
months. No credit was given for other time frames, or for the statement 
that the study would be completed in six months or more. 
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APPENDIX S: INSTITUTIONAL PERMISSIONS TO COLLECT DATA 
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1200 Pleasant Sireei. Des Moines lowo 50309 fbi 51283-6212 
" IOWA METHODIST HEALTH SYSTEM 
August 27, 1991 
Kenneth R. Mills 
Clinical Psychology 
Iowa Methodist Medical Center 
RE: R & I Grant Request #506 KRM; CONSENT 
Dear Ken: 
Your proposal for a study on the effectiveness of different 
methods of consent information presentation was approved by the 
Research and Innovation Center Advisory Committee at its 
meeting on August 21, 1991. There was no question regarding 
the proposed materials to be reviewed by the subjects. Please 
forward a copy of the approval by the ISU Human Subjects 
Committee when it is received. 
Also please forward to the committee the procedure you will 
follow regarding protection of the confidentiality of the 
patient in the interviewing process, accessing patient records, 
and reporting the results. 
Should you have any questions or concerns regarding this 
approval please contact me at 283-5761. Best wishes in the 
conduct of your study. If I can be of any assistance in the 
course of the study, please call. The Committee looks forward 
to receiving a report of your study. 
Sincerely, 
Keith L. McRoberts, Ph.D., P.E. 
Director, Research and Innovation Center 
KLM/cfw 
cc: Juli Taylor, Accounting 
Ivan Lyddon, IMHF 
Joyce Keen, Clinical Psychology 
LTR/ADO 7/KLM/MILLS 
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INTER-OFFICE CORRESPONDENCE 
loiva Mi.'ltiorlisI Mnflifnl Conlnr 
Moiiicv. loiva 
TO: Ken Mills 
Clinical Psychology" 
FROM; Kathy Stone \/ ^  
Powell CDC Lx 
DATE: August 30, 1991 
RE: Research Proposal 
I have reviewed the proposal you sent me for a planned study on the 
effectiveness of different methods of presentation of consent information to 
chronic alcoholics. The proposal is very interesting and of potential benefit 
to Powell CDC staff and clients. You can count on our participation in the 
study. 
Please contact me as your plans move forward so we can work out details. 
Thanks! 
KS/pc 
MEMO/MILLS/KS 8/30/91 
OA 2 12/83 (632^43 299) 
226 
Center for Addictions Recovery 
*  +  * * * *  +  * * * * * * * * * * * * * * * *  S e r v i n g  B o o n e  a n d  S t o r y  C o u n t i e s *  * * * * * * » * * * * * * * * *  +  +  +  
September 28,1992 
Ken Mills 
713 Ninth Street 
Ames, Iowa 50010 
Dear Ken; 
This is a letter oHlcially giving you permission to collect the research data lor your 
study entitled "The effect of information redundancy and format upon 
comprehendability of consent information in chronic alcoholics." 
It is our belief that this study will be of mutual benefit to you and to us. 1 hope your 
research will prove valuable. 
511 Duff 
P.O. Box 1721 
Ames, Iowa 50010 
Telephone; 232-3206 
Boone County Hospltal-3rd Floor 
Room 385 
Boone, Iowa 50036 
Telephone: 432-2944 
Sincerely, 
David A. Sahr, 
Executive Director 
Effective Treatment Toward Successful Recovery 
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SUBSTANCE ABUSE i REAIMEM I "l !l F of CEHIRAL IOWA 
October 16, 1992 
TO WHOM IT MAY CONCERN: 
The Substance Abuse Treatment Unit of Central Iowa Board of Directors 
have officially given Mr. Ken Mills permission to collect research data 
as needed. 
Vickie F. Lewis 
Director of Professional Services 
PREVENTION OFFICE HARDIN COUISTY MARSHALL COUNTY POWESHIEK COUNTY TAMA COUNTY 
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M EASE REPLY TO, 
• CENTRAL TREATMENT and OFFICE FACII.ITY 
•1*0 StiiithK^iv Avnuii* Iowa (.Hy. Iiiwa SJ2 III 319 3SI.-<J57 PAX: 3l9-35t («)ir 
• CEDAR COUNTY BRANCH OFFICE 
Ct-ilar CiKintv < nurilmiiM-Hum,, n 2 I liiwa AlV HH«, 4 lf,H 
O IOWA COUNTY BRANCH OFFICE 
First Intersiaie Bank 1101 Court Avenue. Suite 10 P() Box 366 Marengd. Iowa 52301 31») (ii2 SS2H 
O WASHINGTON COUNTY BRANCH OFFICE 
Wa5hinKi(>n (:i,un;y Hospital 400 FaM I'olk Wishingion, Iowa S23S3 319 653 7S97 
• HEALTH IOWA BRANCH OFFICE 
.Student Health Services StvinUk-r Uuddlng l.'nivcrslty of Iowa I«iwa City. Iowa 52242 319-335-8392 
Uf>iVf»f| \V>i| 
MID-EASTERN COIINCII. ON CHEMICAL ABUSE 
< CIMI'lirill VMM >1 lis I I Ull M IIIIMMI.M AM) I'lll \ IN IK 1\ SI HVK l;S 
Mll\l\(i I IDAR. KIWA imiNSDN. AM) WASIIIM.ION I III MHS 
September 30, 1992 
To Whom it May Concern: 
This letter is to verify thnt Ken Mills linn cocoived our permission to 
interview M.E.C.C.A. clients for the purpose of conducting research. 
Mr. Mills will initially interview clients on October 2nd, 1992, any 
subsequent appointments will be arranged through Fonda Frazier or with 
the clients themselves with our standing permission. 
r J. Schut 
Executive Director 
Fonda'Frazier, Msfl., CAC III 
Clinical Director/ 
